Gene	Gene synonym	Ensembl	Gene description	Uniprot	Chromosome	Position	Protein class	Biological process	Molecular function	Disease involvement	Evidence	HPA evidence	UniProt evidence	NeXtProt evidence	MS evidence	RNA tissue specificity	RNA tissue distribution	RNA tissue specificity score	RNA tissue specific NX	RNA single cell type specificity	RNA single cell type distribution	RNA single cell type specificity score	RNA single cell type specific NX	RNA cancer specificity	RNA cancer distribution	RNA cancer specificity score	RNA cancer specific FPKM	RNA brain regional specificity	RNA brain regional distribution	RNA brain regional specificity score	RNA brain regional specific NX	RNA blood cell specificity	RNA blood cell distribution	RNA blood cell specificity score	RNA blood cell specific NX	RNA blood lineage specificity	RNA blood lineage distribution	RNA blood lineage specificity score	RNA blood lineage specific NX	RNA cell line specificity	RNA cell line distribution	RNA cell line specificity score	RNA cell line specific NX	RNA mouse brain regional specificity	RNA mouse brain regional distribution	RNA mouse brain regional specificity score	RNA mouse brain regional specific pTPM	RNA pig brain regional specificity	RNA pig brain regional distribution	RNA pig brain regional specificity score	RNA pig brain regional specific pTPM	Antibody	Reliability (IH)	Reliability (Mouse Brain)	Reliability (IF)	Subcellular location	Secretome location	CCD Protein	CCD Transcript	Blood concentration - Conc. blood IM [pg/L]	Blood concentration - Conc. blood MS [pg/L]	Subcellular main location	Subcellular additional location	Antibody RRID	Pathology prognostics - Breast cancer	Pathology prognostics - Cervical cancer	Pathology prognostics - Colorectal cancer	Pathology prognostics - Endometrial cancer	Pathology prognostics - Glioma	Pathology prognostics - Head and neck cancer	Pathology prognostics - Liver cancer	Pathology prognostics - Lung cancer	Pathology prognostics - Melanoma	Pathology prognostics - Ovarian cancer	Pathology prognostics - Pancreatic cancer	Pathology prognostics - Prostate cancer	Pathology prognostics - Renal cancer	Pathology prognostics - Stomach cancer	Pathology prognostics - Testis cancer	Pathology prognostics - Thyroid cancer	Pathology prognostics - Urothelial cancer	Tissue RNA - adipose tissue [NX]	Tissue RNA - adrenal gland [NX]	Tissue RNA - amygdala [NX]	Tissue RNA - appendix [NX]	Tissue RNA - basal ganglia [NX]	Tissue RNA - bone marrow [NX]	Tissue RNA - breast [NX]	Tissue RNA - cerebellum [NX]	Tissue RNA - cerebral cortex [NX]	Tissue RNA - cervix, uterine [NX]	Tissue RNA - colon [NX]	Tissue RNA - corpus callosum [NX]	Tissue RNA - ductus deferens [NX]	Tissue RNA - duodenum [NX]	Tissue RNA - endometrium 1 [NX]	Tissue RNA - epididymis [NX]	Tissue RNA - esophagus [NX]	Tissue RNA - fallopian tube [NX]	Tissue RNA - gallbladder [NX]	Tissue RNA - heart muscle [NX]	Tissue RNA - hippocampal formation [NX]	Tissue RNA - hypothalamus [NX]	Tissue RNA - kidney [NX]	Tissue RNA - liver [NX]	Tissue RNA - lung [NX]	Tissue RNA - lymph node [NX]	Tissue RNA - midbrain [NX]	Tissue RNA - olfactory region [NX]	Tissue RNA - ovary [NX]	Tissue RNA - pancreas [NX]	Tissue RNA - parathyroid gland [NX]	Tissue RNA - pituitary gland [NX]	Tissue RNA - placenta [NX]	Tissue RNA - pons and medulla [NX]	Tissue RNA - prostate [NX]	Tissue RNA - rectum [NX]	Tissue RNA - retina [NX]	Tissue RNA - salivary gland [NX]	Tissue RNA - seminal vesicle [NX]	Tissue RNA - skeletal muscle [NX]	Tissue RNA - skin 1 [NX]	Tissue RNA - small intestine [NX]	Tissue RNA - smooth muscle [NX]	Tissue RNA - spinal cord [NX]	Tissue RNA - spleen [NX]	Tissue RNA - stomach 1 [NX]	Tissue RNA - testis [NX]	Tissue RNA - thalamus [NX]	Tissue RNA - thymus [NX]	Tissue RNA - thyroid gland [NX]	Tissue RNA - tongue [NX]	Tissue RNA - tonsil [NX]	Tissue RNA - urinary bladder [NX]	Tissue RNA - vagina [NX]	Tissue RNA - B-cells [NX]	Tissue RNA - dendritic cells [NX]	Tissue RNA - granulocytes [NX]	Tissue RNA - monocytes [NX]	Tissue RNA - NK-cells [NX]	Tissue RNA - T-cells [NX]	Tissue RNA - total PBMC [NX]	Cell RNA - A-431 [NX]	Cell RNA - A549 [NX]	Cell RNA - AF22 [NX]	Cell RNA - AN3-CA [NX]	Cell RNA - ASC diff [NX]	Cell RNA - ASC TERT1 [NX]	Cell RNA - BEWO [NX]	Cell RNA - BJ [NX]	Cell RNA - BJ hTERT+ [NX]	Cell RNA - BJ hTERT+ SV40 Large T+ [NX]	Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]	Cell RNA - CACO-2 [NX]	Cell RNA - CAPAN-2 [NX]	Cell RNA - Daudi [NX]	Cell RNA - EFO-21 [NX]	Cell RNA - fHDF/TERT166 [NX]	Cell RNA - GAMG [NX]	Cell RNA - HaCaT [NX]	Cell RNA - HAP1 [NX]	Cell RNA - HBEC3-KT [NX]	Cell RNA - HBF TERT88 [NX]	Cell RNA - HDLM-2 [NX]	Cell RNA - HEK 293 [NX]	Cell RNA - HEL [NX]	Cell RNA - HeLa [NX]	Cell RNA - Hep G2 [NX]	Cell RNA - HHSteC [NX]	Cell RNA - HL-60 [NX]	Cell RNA - HMC-1 [NX]	Cell RNA - HSkMC [NX]	Cell RNA - hTCEpi [NX]	Cell RNA - hTEC/SVTERT24-B [NX]	Cell RNA - hTERT-HME1 [NX]	Cell RNA - hTERT-RPE1 [NX]	Cell RNA - HUVEC TERT2 [NX]	Cell RNA - JURKAT [NX]	Cell RNA - K-562 [NX]	Cell RNA - Karpas-707 [NX]	Cell RNA - LHCN-M2 [NX]	Cell RNA - MCF7 [NX]	Cell RNA - MOLT-4 [NX]	Cell RNA - NB-4 [NX]	Cell RNA - NTERA-2 [NX]	Cell RNA - OE19 [NX]	Cell RNA - PC-3 [NX]	Cell RNA - REH [NX]	Cell RNA - RH-30 [NX]	Cell RNA - RPMI-8226 [NX]	Cell RNA - RPTEC TERT1 [NX]	Cell RNA - RT4 [NX]	Cell RNA - SCLC-21H [NX]	Cell RNA - SH-SY5Y [NX]	Cell RNA - SiHa [NX]	Cell RNA - SK-BR-3 [NX]	Cell RNA - SK-MEL-30 [NX]	Cell RNA - SuSa [NX]	Cell RNA - T-47d [NX]	Cell RNA - THP-1 [NX]	Cell RNA - TIME [NX]	Cell RNA - U-138 MG [NX]	Cell RNA - U-2 OS [NX]	Cell RNA - U-2197 [NX]	Cell RNA - U-251 MG [NX]	Cell RNA - U-266/70 [NX]	Cell RNA - U-266/84 [NX]	Cell RNA - U-698 [NX]	Cell RNA - U-87 MG [NX]	Cell RNA - U-937 [NX]	Cell RNA - WM-115 [NX]	Blood RNA - basophil [NX]	Blood RNA - classical monocyte [NX]	Blood RNA - eosinophil [NX]	Blood RNA - gdT-cell [NX]	Blood RNA - intermediate monocyte [NX]	Blood RNA - MAIT T-cell [NX]	Blood RNA - memory B-cell [NX]	Blood RNA - memory CD4 T-cell [NX]	Blood RNA - memory CD8 T-cell [NX]	Blood RNA - myeloid DC [NX]	Blood RNA - naive B-cell [NX]	Blood RNA - naive CD4 T-cell [NX]	Blood RNA - naive CD8 T-cell [NX]	Blood RNA - neutrophil [NX]	Blood RNA - NK-cell [NX]	Blood RNA - non-classical monocyte [NX]	Blood RNA - plasmacytoid DC [NX]	Blood RNA - T-reg [NX]	Blood RNA - total PBMC [NX]	Brain RNA - amygdala [NX]	Brain RNA - basal ganglia [NX]	Brain RNA - cerebellum [NX]	Brain RNA - cerebral cortex [NX]	Brain RNA - hippocampal formation [NX]	Brain RNA - hypothalamus [NX]	Brain RNA - midbrain [NX]	Brain RNA - olfactory region [NX]	Brain RNA - pons and medulla [NX]	Brain RNA - thalamus [NX]	Single Cell Type RNA - Alveolar cells type 1 [NX]	Single Cell Type RNA - Alveolar cells type 2 [NX]	Single Cell Type RNA - B-cells [NX]	Single Cell Type RNA - Basal glandular cells [NX]	Single Cell Type RNA - Basal keratinocytes [NX]	Single Cell Type RNA - Bipolar cells [NX]	Single Cell Type RNA - Cardiomyocytes [NX]	Single Cell Type RNA - Cholangiocytes [NX]	Single Cell Type RNA - Ciliated cells [NX]	Single Cell Type RNA - Club cells [NX]	Single Cell Type RNA - Collecting duct cells [NX]	Single Cell Type RNA - Cone photoreceptor cells [NX]	Single Cell Type RNA - Cytotrophoblasts [NX]	Single Cell Type RNA - Distal tubular cells [NX]	Single Cell Type RNA - Ductal cells [NX]	Single Cell Type RNA - Early spermatids [NX]	Single Cell Type RNA - Endothelial cells [NX]	Single Cell Type RNA - Enterocytes [NX]	Single Cell Type RNA - Erythroid cells [NX]	Single Cell Type RNA - Exocrine glandular cells [NX]	Single Cell Type RNA - Extravillous trophoblasts [NX]	Single Cell Type RNA - Fibroblasts [NX]	Single Cell Type RNA - Glandular cells [NX]	Single Cell Type RNA - granulocytes [NX]	Single Cell Type RNA - Hepatocytes [NX]	Single Cell Type RNA - Hofbauer cells [NX]	Single Cell Type RNA - Horizontal cells [NX]	Single Cell Type RNA - Intestinal endocrine cells [NX]	Single Cell Type RNA - Ito cells [NX]	Single Cell Type RNA - Kupffer cells [NX]	Single Cell Type RNA - Late spermatids [NX]	Single Cell Type RNA - Leydig cells [NX]	Single Cell Type RNA - Macrophages [NX]	Single Cell Type RNA - Melanocytes [NX]	Single Cell Type RNA - monocytes [NX]	Single Cell Type RNA - Mucus-secreting cells [NX]	Single Cell Type RNA - Muller glia cells [NX]	Single Cell Type RNA - Pancreatic endocrine cells [NX]	Single Cell Type RNA - Paneth cells [NX]	Single Cell Type RNA - Peritubular cells [NX]	Single Cell Type RNA - Proximal tubular cells [NX]	Single Cell Type RNA - Rod photoreceptor cells [NX]	Single Cell Type RNA - Sertoli cells [NX]	Single Cell Type RNA - Smooth muscle cells [NX]	Single Cell Type RNA - Spermatocytes [NX]	Single Cell Type RNA - Spermatogonia [NX]	Single Cell Type RNA - Suprabasal keratinocytes [NX]	Single Cell Type RNA - Syncytiotrophoblasts [NX]	Single Cell Type RNA - T-cells [NX]	Single Cell Type RNA - Undifferentiated cells [NX]	Single Cell Type RNA - Urothelial cells [NX]	RNAsingleCellTypeSpecific
DCUN1D1	DCUN1L1, RP42, SCCRO, SCRO, Tes3	ENSG00000043093	Defective in cullin neddylation 1 domain containing 1	Q96GG9	3	182938074-182985953	Predicted intracellular proteins	Ubl conjugation pathway		Proto-oncogene	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in all	5	testis: 95.0	Cell type enriched	Detected in all	4	Late spermatids: 9862.3	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all							Low region specificity	Detected in all			HPA035911	Uncertain		Approved	Nucleoplasm,Cytosol					70000	Nucleoplasm	Cytosol	HPA035911: AB_10673489	unprognostic (2.13e-1)	unprognostic (2.36e-1)	unprognostic (4.83e-3)	unprognostic (1.94e-3)	unprognostic (1.44e-3)	unprognostic (6.06e-2)	unprognostic (5.93e-2)	unprognostic (1.72e-2)	unprognostic (9.34e-2)	unprognostic (9.25e-3)	unprognostic (4.98e-3)	unprognostic (7.26e-2)	unprognostic (1.01e-3)	unprognostic (1.52e-1)	unprognostic (2.12e-1)	unprognostic (5.01e-2)	unprognostic (3.52e-1)	5	5.2	7.9	5	7.1	6.9	4.8	9.3	8.3	4.5	4.9	4.1	2.7	4.9	5.4	4.9	6.7	4.3	4.6	5.5	7.4	5	7.2	11.2	4.3	5	9.3	6.8	4.7	3.6	4.6	14.6	4.5	8	6.1	4.8	2.8	4.9	5.4	14.7	5.2	6.5	8.1	9.2	5.2	4.2	95	7.6	7.2	6.7	5.2	6	8.4	4.9	7.4	10.7	17.3	9.8	11.2	8	5.7	23.3	10.4	13.9	6	14.7	14.5	11.8	15	16.9	16.9	16.6	15.3	17.4	27.4	33	14	25.5	13.1	11.6	12	22.5	22.4	6.3	26.4	8.1	6.4	9.3	15.5	19.9	10.3	14.7	9.4	8.9	12.5	11.6	16.8	8.8	14.4	12.3	12.5	15.2	8.3	11.3	17.6	9.5	12	14.7	18.1	12.2	16.5	10.1	10.1	26.3	18.9	14.1	15.3	38.7	12.6	11.2	10.5	10.1	14.3	17.6	11.9	22	27.8	13.2	14.7	15.1	9.4	9.1	17.3	7.8	9.8	7.5	7.4	6.4	7.7	10.7	4.7	7.5	7.9	15	11.2	6.3	8.2	8	5.7	7.9	7.1	9.3	8.3	7.4	5	9.3	6.8	8	7.6	20.8	25.6	17.1	21.7	38.5	14.2	28.2	17.8	20.1	27.3	45.4	9.8	16.2	31.5	26.1	2225.5	18.8	26.6	46.7	26.5	15.7	27.7	32.3	28.9	42.3	24.9	17.5	25.8	17.8	32.1	9862.3	80.3	36.4	11.8	45.1	19.9	16.6	27.2	23.4	60.5	33.6	20.5	77.6	25.5	86.4	52	37.1	16.7	25.3	19.6	34.8	Late spermatids
ACAP1	CENTB1, KIAA0050	ENSG00000072818	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	Q15027	17	7336529-7351478	Cancer-related genes, Plasma proteins, Predicted intracellular proteins	Protein transport, Transport	GTPase activation	Cancer-related genes	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		blood: 29.4;bone marrow: 30.3;lymphoid tissue: 51.5	Cell type enriched	Detected in many	5	Late spermatids: 2487.1	Low cancer specificity	Detected in all			Low region specificity	Detected in many			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Cell line enhanced	Detected in some		Daudi: 17.5;HDLM-2: 23.1;JURKAT: 32.7;Karpas-707: 22.9;NB-4: 28.3;U-937: 18.7	Not detected	Not detected			Low region specificity	Detected in many			HPA075570	Approved		Approved	Golgi apparatus						Golgi apparatus		HPA075570: AB_2732295	unprognostic (1.20e-2)	prognostic favorable (3.66e-4)	unprognostic (2.49e-1)	prognostic favorable (2.97e-5)	unprognostic (4.43e-4)	prognostic favorable (4.17e-5)	unprognostic (5.66e-3)	unprognostic (1.11e-2)	unprognostic (4.67e-2)	unprognostic (2.48e-2)	unprognostic (1.42e-2)	unprognostic (1.91e-1)	prognostic unfavorable (1.65e-10)	unprognostic (1.14e-1)	unprognostic (5.58e-2)	unprognostic (2.90e-1)	unprognostic (8.61e-3)	2.6	0.6	0.6	31.4	1.3	30.3	1.1	1	1.2	1.4	4.5	0.4	0.4	3.2	0.9	1.5	3.3	2	3.1	1.4	0.6	0.6	2.9	2.3	7.3	29.3	2.7	0.1	1	0.7	0	0.8	0.5	1.2	1.8	1.5	1.7	9.6	1.3	0.5	1.2	19.2	0.8	1.3	44.9	3.7	1.4	0.9	51.5	2.5	1	33.9	3.7	1.8	17.8	13.3	22.4	5.9	23.7	29.4	16.1	0	0	0	0	0	0	0	0.2	0	0.1	0.1	0	0	17.5	0.1	0	0	0	0	0	0	23.1	0	6.6	0.1	0	0	8.5	0.3	0	0	0	0	0	0	32.7	0	22.9	0	0	10.6	28.3	0.3	0	0	11.3	0.1	2.6	0	0	0	0	0	0	0	0.1	0	6.7	0	0	0.1	0	0	7.1	6	8	0.1	18.7	0	17	5.9	22.4	24.6	1.8	27.5	16.6	25.8	26.1	10.5	17.8	22.7	22.4	17.7	23.7	0.2	13.3	29.4	16.1	0.6	1.3	1	1.2	0.6	0.6	2.7	0.1	1.2	0.9	8.9	8.5	123.3	5.5	7.3	14.8	26.2	10.2	28.1	11.4	5.2	17.7	3.1	6.6	3.5	485	7.1	1.3	0	3	2.2	12.2	3.7	39.3	4.9	7.7	0	3.5	6.7	23.4	2487.1	18.7	24.9	23.6	19	2	9.6	4.6	0	14.5	3.6	19.3	19.4	8.5	14.2	10.7	6.5	3.7	282.4	1	3	Late spermatids
RANGAP1	Fug1, KIAA1835, SD	ENSG00000100401	Ran GTPase activating protein 1	P46060	22	41245611-41286251	Plasma proteins, Predicted intracellular proteins, Transporters		GTPase activation		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	5	Late spermatids: 1320.8	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			CAB004293, HPA050110, HPA062034	Supported		Enhanced	Nuclear membrane,Vesicles,Cytosol		Yes	Yes			Nuclear membrane	Vesicles, Cytosol	CAB004293: AB_2176987, HPA050110: AB_2681018, HPA062034: AB_2684667	unprognostic (1.30e-2)	unprognostic (3.16e-2)	unprognostic (1.66e-1)	unprognostic (7.97e-2)	unprognostic (2.57e-1)	unprognostic (2.54e-1)	prognostic unfavorable (1.08e-4)	unprognostic (8.28e-3)	unprognostic (8.09e-2)	unprognostic (9.87e-2)	unprognostic (5.84e-2)	unprognostic (7.56e-2)	unprognostic (7.07e-3)	prognostic favorable (5.39e-4)	unprognostic (2.06e-1)	unprognostic (2.74e-1)	unprognostic (2.68e-1)	12.2	30.7	23.5	16.9	28.4	28.5	16.1	17.6	41.1	8.5	11.8	23.1	7.3	12.7	9.5	9.4	26.1	11.5	13.7	11.5	26.9	30.4	12	25.1	11.5	19.5	31.7	28.6	10.6	20.2	11	17.7	16.1	28.1	11.4	9.6	7.1	16.3	13.3	12.5	51.6	12.8	12.3	22	14.2	16	64.3	28.3	22.1	12.7	14.4	21.7	13.3	29.2	8.7	7.6	8.2	14.8	7.1	13.1	9.7	58.2	30.6	20	20.9	10.8	8.9	24.3	50.5	27.6	51	26.7	37.1	19.2	31.4	40.8	37	24.6	54.3	36.3	39.8	30.8	25.4	56.3	26.6	29.9	28.9	13.5	42.9	20	8.6	19	36.3	32.2	16.8	26.7	11.8	34.1	22.4	29	49.9	25	34.9	21.8	53.1	36.4	30.7	19.7	33.1	19.9	33.4	18.2	12.1	35.9	31.8	18.5	19.2	18.7	17.3	41.2	39.1	37.5	21.5	41.5	16.7	22.2	29.9	27.3	30.5	22.5	2.8	9.5	8.2	11.2	11.2	13.1	7.9	11.3	10.3	7.1	8.7	10.5	8	2.7	7.1	14.8	7.6	11.6	9.7	23.5	28.4	17.6	41.1	26.9	30.4	31.7	28.6	28.1	28.3	3	24.7	28.1	17.5	20.5	15.2	17.4	22.9	9.4	9.1	8.7	13.7	15.1	3.3	34.2	259.8	12.7	10.1	0	17.4	28.1	9.3	32.2	5.8	17.9	14	14.3	24	11.6	13.4	1320.8	13.8	17.1	11.8	10	13.9	7.8	29	6.5	11.3	11.2	24.4	0	9	18	19.2	27	19.8	23.8	10.9	19.2	Late spermatids
PARD6A	PAR-6, PAR-6A, PAR6alpha, TAX40, TIP-40	ENSG00000102981	Par-6 family cell polarity regulator alpha	Q9NPB6	16	67660946-67662778	Plasma proteins, Predicted intracellular proteins	Cell cycle, Cell division			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		brain: 26.8;pancreas: 31.0	Cell type enriched	Detected in many	5	Late spermatids: 203.1	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Cell line enhanced	Detected in many		REH: 17.4	Low region specificity	Detected in all			Low region specificity	Detected in all			CAB009733, HPA041551	Approved		Supported	Cell Junctions,Actin filaments,Cytosol		No	No			Cell Junctions, Actin filaments	Cytosol	CAB009733: AB_2159676, HPA041551: AB_2677545	prognostic favorable (5.40e-4)	unprognostic (6.18e-2)	unprognostic (1.77e-1)	unprognostic (1.33e-2)	unprognostic (7.63e-2)	unprognostic (4.08e-3)	unprognostic (1.23e-2)	unprognostic (1.27e-1)	unprognostic (6.59e-2)	unprognostic (2.09e-1)	unprognostic (1.98e-3)	unprognostic (9.13e-2)	prognostic favorable (3.08e-7)	unprognostic (9.22e-3)	unprognostic (6.69e-2)	unprognostic (1.25e-1)	unprognostic (1.39e-2)	2.7	6.1	11.7	3.5	12.4	2.1	2.8	26.8	16.1	2	3	2.2	3.7	2	2.4	3.6	2.7	2.5	3.1	2.3	13.8	7.2	5.5	3.1	3.5	4	7.9	5.7	3.3	31	5.3	13.9	1.5	7.4	2.7	2	1.4	3.8	4.6	7	1.5	2.5	2.7	3.7	3.7	3.2	16.9	3.4	2.5	2.3	1.4	3.4	2.9	3.1	11.4	5.3	3.7	1	1.2	8.5	2.1	5.5	6	1.7	14.8	1.2	0.2	3.1	0.1	0.7	2.2	2.1	3	2.3	9.4	2.8	0.1	0.8	4.4	3.4	0.7	0.5	4.4	3.2	3.8	2.8	3.4	1.6	1.5	8.9	0.1	0.3	2.1	0.8	1.4	1.1	14.1	0.3	2.2	0.4	5.5	9.6	2	2	7.7	3.9	17.4	1.1	15.2	5.9	3.2	14.3	7.7	0.9	2.1	2.3	0.5	12.9	0.6	0.9	0.2	0.5	1.4	2.9	2.3	7.3	8.4	1.7	3.4	0.6	2.1	1	0.4	4.5	0.5	8.5	11.4	6.4	5.9	1.2	7.4	3.2	2.4	3.7	1.2	0.1	5.3	6.1	2.1	11.7	12.4	26.8	16.1	13.8	7.2	7.9	5.7	7.4	3.4	3	4.3	8.1	1.4	0.8	9.7	1	12.7	4	2.3	19.2	3.9	4.6	28.2	6.6	42.8	2.7	2.1	0	13.1	0.2	2.4	2.1	5.7	3.8	4	30.2	32.6	1.3	3.2	203.1	3.4	3.1	5	1	2.4	15.2	5.2	2.6	1.4	12.9	7.6	0	2.1	4.6	2.6	1.4	2.4	9.6	2.9	1.4	Late spermatids
GAPDHS	GAPD2, GAPDH-2, GAPDS	ENSG00000105679	Glyceraldehyde-3-phosphate dehydrogenase, spermatogenic	O14556	19	35533412-35545316	Enzymes, Plasma proteins, Predicted intracellular proteins	Glycolysis	Oxidoreductase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	35	testis: 154.6	Cell type enriched	Detected in some	4	Late spermatids: 6946.0	Cancer enriched	Detected in single	97	melanoma: 13.3	Not detected	Not detected			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		A549: 16.5	Not detected	Not detected			Low region specificity	Detected in all			HPA042666	Enhanced		Approved	Nucleoplasm,Centrosome						Nucleoplasm	Centrosome	HPA042666: AB_2678104	unprognostic (3.74e-1)	unprognostic (1.59e-1)			unprognostic (7.41e-2)			unprognostic (1.56e-1)	unprognostic (2.06e-1)	unprognostic (1.04e-1)	unprognostic (8.81e-2)			unprognostic (2.96e-1)	unprognostic (1.03e-1)	unprognostic (6.45e-3)	unprognostic (2.37e-1)	0.3	0.5	0.3	0.8	0.3	0.2	0.3	0.3	0.4	0.3	0.3	0.3	0.3	0.6	0.5	1.6	0.6	0.2	0.8	0.8	0.3	0.3	0.3	0.3	0.3	1.6	0.3	0.3	0.7	1.3	0	0.3	0.3	0.3	0.3	0	4.2	1.3	0.3	0.3	4.4	0.6	0.3	0.3	1.2	0.4	154.6	0.3	0.3	3.6	0.3	0.3	0.6	0.3	2.1	1	1.2	0.8	1.4	2	0.8	4.5	16.5	4.6	6.9	0	0	3.9	1.3	0	0	0	10	7.6	7.5	2.2	0	1.9	5.5	0	0	0	7.3	8	5	10.5	5.1	0.1	4.5	6	0	0	0	0	2.9	0	7.3	12	4.4	0	14.1	1.7	2.1	6.2	2.9	2.2	5.3	3.2	5.8	0	4.5	8.3	3.7	1.7	4.2	4.9	3.3	3.4	1.9	1.5	5.3	6	1.3	1.9	12.3	3.3	4.4	2.9	8.1	1.9	0	0.8	1.2	1.1	0.6	2	1.1	0.4	1.9	1	2.1	1.1	1.2	0	1.4	0.3	0.8	0.3	0.8	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0	0	0	0	2.2	0	0	0	0	0	0	0	0	0	0	1712.2	0	0	0	0.2	0	0.2	0	0	0	0.1	0	0	1.3	0	6946	23	0	42.2	0	0	0	0	0	26.9	0	0	25.8	0.2	30.4	13.5	0.1	0	0	0	0	Late spermatids
FSCN3		ENSG00000106328	Fascin actin-bundling protein 3	Q9NQT6	7	127591409-127602144	Predicted intracellular proteins		Actin-binding		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	54	testis: 62.1	Cell type enriched	Detected in some	6	Late spermatids: 1905.7	Not detected	Not detected			Not detected	Not detected			Cell type enhanced	Detected in single		myeloid DC: 1.1	Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		hTCEpi: 2.5	Not detected	Not detected			Not detected	Not detected			HPA075174	Enhanced											HPA075174: 	unprognostic (7.77e-2)	unprognostic (1.57e-1)	unprognostic (2.17e-1)	unprognostic (9.59e-2)	unprognostic (1.39e-1)	unprognostic (3.87e-1)	unprognostic (5.69e-2)	unprognostic (1.50e-1)	unprognostic (2.91e-3)	unprognostic (2.00e-1)	unprognostic (1.68e-4)	unprognostic (1.34e-1)	unprognostic (1.14e-5)	unprognostic (1.27e-1)	unprognostic (9.21e-3)	unprognostic (2.01e-1)	unprognostic (7.34e-2)	0	0	0	0	0	0.2	0	0.2	0	0	0	0	0	0	0.1	0.7	0	0.1	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0.2	0	0	0	0	0	62.1	0	0	0	0	0	0	0	0.1	1.1	0.3	0	0	0.3	0	0	1.1	0.3	0.8	0	0	1.4	0.1	0.4	0.3	0	0.2	0.2	0	0.1	0	0	0	0.5	0	0	0.9	0	0	0.6	0	0	0	0	0.9	2.5	0.6	0	0	0	0.5	0.3	0.6	0	0.7	0.7	0.7	1.4	0	0	0.5	0.7	0.2	0	0.5	0.2	0.3	0	1.5	0	0.3	0	0.6	0	0.1	0.1	0.5	0	0.8	0.3	0.7	0	0.3	0.9	0	0	0	0	0	0	0	0	0.3	1.1	0.1	0	0	0.3	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	1.4	0	0.4	0.7	0	0.3	0	0	0	0	0	0.3	0	0.3	317.1	0.3	0	0	0.2	0.2	0.2	0.3	1.1	0	0.1	0	0	0	0	1905.7	8.6	0.9	1.7	0	0.1	0.2	0.2	0.6	7.8	0	0.4	0	0.3	9.8	5.8	1.1	0.2	0	0.1	0.1	Late spermatids
MOSPD3	CDS3, NET30	ENSG00000106330	Motile sperm domain containing 3	O75425	7	100612102-100615384	Predicted membrane proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	4	Late spermatids: 1149.7	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Cell line enhanced	Detected in many		U-937: 33.7	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA041137, HPA048240	Uncertain		Approved	Nucleoplasm,Cytosol		No	No			Nucleoplasm, Cytosol		HPA041137: AB_10803996, HPA048240: AB_2680325	unprognostic (1.24e-1)	unprognostic (8.98e-2)	unprognostic (1.06e-2)	unprognostic (1.08e-1)	unprognostic (1.25e-2)	unprognostic (1.80e-2)	unprognostic (1.19e-1)	unprognostic (5.94e-2)	unprognostic (9.88e-2)	unprognostic (1.66e-1)	unprognostic (2.46e-2)	unprognostic (8.65e-2)	unprognostic (2.24e-2)	unprognostic (7.55e-2)	unprognostic (2.25e-1)	unprognostic (1.09e-1)	unprognostic (3.20e-2)	13.8	22.3	13	7.7	12.8	17.4	9.8	9	16.9	14.7	9.1	14.5	13.9	9.9	12	12.9	22.5	12	14.9	10.2	11.2	10.8	19.3	29.8	11.1	18.5	10.6	11.6	13.1	17.1	6.7	9.8	7.8	12	12.9	4.8	14.9	19.1	11.3	11.3	24.4	10.6	10.3	9.5	11.8	14.7	37	9.9	16.6	12.2	13.6	16.8	12.4	13.4	11.6	17.9	22.2	16.7	20.9	29.7	8	6	8.2	6.6	11.4	3.5	2.6	4.7	4.6	5.5	4.8	4.9	7.6	8.1	3.8	10.2	4.2	6.8	4.7	3.8	6.6	0.9	9.8	5.1	3.9	6.1	11.4	4.5	3	15.1	7.4	5.7	4.1	2.4	4.2	8.2	6.4	9.1	7.8	4.9	17.9	8.4	23	6	7.9	12.4	7.9	6.9	9.1	7.6	9.1	3.6	21.7	8.6	13.4	4.6	2.8	8.1	8.9	9.2	9.3	14.7	19.3	4.4	6.2	5.8	2.6	9.3	33.7	11.4	18.5	16.7	22.2	18.8	12.4	22.2	11.6	21.8	21.8	17.9	11.3	13	13.5	12.3	20.9	8.5	12	29.7	8	13	12.8	9	16.9	11.2	10.8	10.6	11.6	12	9.9	8.9	6.5	11.9	14.9	10.8	6.6	3.2	17.8	9.4	4.5	19.2	5.9	6	36.5	33.9	271.2	15.7	8.7	0	37.6	23.2	22	20.1	3.5	26.2	25.2	6.4	20.7	19	23	1149.7	25.6	15.1	25.3	14.4	14.9	11.4	39	17.5	20.5	35.7	3.4	12.9	20	17.7	21.5	17.1	5.1	29.3	16.9	17.8	Late spermatids
CCNY	C10orf9, CBCP1, CFP1	ENSG00000108100	Cyclin Y	Q8ND76	10	35247025-35572669	Predicted intracellular proteins	Cell cycle, Cell division, Wnt signaling pathway	Cyclin		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	4	Late spermatids: 2886.4	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in all		neutrophil: 18.5	Group enriched	Detected in all	5	dendritic cells: 5.5;granulocytes: 18.5;monocytes: 16.5	Low cell line specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA036290	Approved											HPA036290: AB_10600860	unprognostic (1.25e-2)	unprognostic (1.48e-1)	unprognostic (4.30e-2)	unprognostic (2.23e-3)	unprognostic (1.30e-1)	unprognostic (4.65e-1)	prognostic unfavorable (6.75e-5)	unprognostic (3.37e-2)	unprognostic (6.15e-3)	unprognostic (4.06e-2)	unprognostic (2.94e-1)	unprognostic (1.10e-1)	unprognostic (2.74e-2)	unprognostic (1.31e-1)	unprognostic (3.77e-2)	unprognostic (1.98e-1)	unprognostic (1.80e-1)	21.3	17.1	32.8	15.9	32.1	23.8	17	11.7	29.4	18.1	20.7	25	13.6	17.1	22.4	21.5	17.1	18.2	19.1	24.3	30	20.1	19.8	23.9	20.2	19.1	25.5	16.7	21.2	16.5	14	13.9	29.7	18.1	14.9	15.9	14.5	13.2	16.7	17.3	14.3	23.3	20.5	26.5	17.9	19	67	22.2	20.5	24	14.7	15.8	19	17.8	2.2	5.5	18.5	16.5	1.9	2.7	4.8	22.7	10.5	12.8	12.7	18.6	25.1	17.9	12.3	11.8	11.5	10.9	14.4	23.3	14.4	17.4	18.7	10.3	12.2	11.4	15.2	11.9	47.3	7.5	26.5	7.3	17.8	19.9	9.3	13	18.2	20.8	18	12	25.2	27.6	16.8	21.4	12.1	22.2	14.6	17	7.8	5	12.6	20.4	14.2	23.4	8.9	14	10.7	11.8	18	9.3	19.2	16.3	11.6	16.8	18.2	33	14.8	17.9	22.5	10.5	8.4	7.4	10.7	25.7	19.9	6.7	1	16.5	3.5	2.5	4.7	2.7	2.2	2.4	2.6	5.5	1.7	2.5	2.7	18.5	1.9	2.2	2.7	1.6	4.8	32.8	32.1	11.7	29.4	30	20.1	25.5	16.7	18.1	22.2	29.8	23.4	20.6	12.1	23.9	41.9	29.9	50.9	12	20.5	36.6	19.6	10.5	5	14	676.5	51.4	21.3	0	23.9	15	31	20.1	16.1	77.8	25.2	46.1	50.7	30.7	74.8	2886.4	38.3	32.7	15.1	16.2	33.9	44.2	23.1	14	36.4	18	32.1	6.5	24.7	26.3	38.7	25.7	7.9	21.8	24.7	17	Late spermatids
CHRNE	ACHRE	ENSG00000108556	Cholinergic receptor nicotinic epsilon subunit	Q04844	17	4897774-4903074	Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters	Ion transport, Transport	Ion channel, Ligand-gated ion channel, Receptor	Congenital myasthenic syndrome, Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in some	6	heart muscle: 53.3;pituitary gland: 19.0	Cell type enriched	Detected in many	5	Late spermatids: 132.7	Low cancer specificity	Detected in some			Not detected	Not detected			Cell type enhanced	Detected in many		gdT-cell: 5.9	Low lineage specificity	Detected in many			Group enriched	Detected in some	13	HEL: 6.0;HMC-1: 15.1	Low region specificity	Detected in single			Region enriched	Detected in single	13	basal ganglia: 5.7														unprognostic (2.00e-3)	unprognostic (1.56e-1)	unprognostic (3.94e-2)	unprognostic (4.35e-3)	unprognostic (6.55e-2)	unprognostic (2.27e-3)	unprognostic (7.80e-4)	unprognostic (7.75e-2)	unprognostic (3.24e-1)	unprognostic (1.34e-1)	unprognostic (3.69e-2)	unprognostic (6.58e-2)	unprognostic (8.42e-4)	unprognostic (1.39e-3)	unprognostic (1.26e-1)	unprognostic (5.83e-2)	unprognostic (5.70e-2)	0.3	0.1	0.1	0.4	0.1	0.4	0.1	0.3	0.4	0.1	0.2	0.1	0.1	0.3	0.4	0.8	0.2	0.1	0.4	53.3	0.1	0	0.1	1.3	0.3	0.2	0.3	0.1	0.3	0.6	0.3	19	0.4	0.2	0.1	0	0.5	0.5	0.1	1	0.8	0.1	0.2	0.1	0.7	0.1	0.2	0.1	0.1	0.1	1.4	0.2	0.1	0.1	1	0.3	1	0.4	1.6	5.9	1.5	0	0	0.6	0	0	0	0.5	0.3	0	0	0.1	0	0	0.3	0.3	0.1	0	0	0	0	0	0.2	0.2	6	0	0.7	0.5	0	15.1	0.6	0	0	0	0.1	0	0.1	0	0	0	0	0	0.3	0	0	0.1	0	0.1	0.4	0	0	0	0	0	0	0	0.1	0	0.8	0	0.1	0	0	0	0.2	0	0	0	0	0.1	0	0.2	1	5.9	0.2	0	0	0	2.1	0.2	1	0.1	1.6	0.2	1.6	0.4	0.3	0	1.5	0.1	0.1	0.3	0.4	0.1	0	0.3	0.1	0.2	0.1	0	0	0	1.1	1.4	0.8	6.3	2.5	0	0	1.8	3.9	0.4	1.7	0.1	27.7	1.4	0	0	0.8	6.2	2.6	0.9	8.1	5.9	3.1	3.2	0	3.7	1.8	132.7	0.9	5.7	0	8.2	0	1.2	0.8	0	0.4	1.1	10	0	0.5	4.3	3	1	9.3	3.2	0.1	0.6	Late spermatids
DNAJC4	HSPF2, MCG18	ENSG00000110011	DnaJ heat shock protein family (Hsp40) member C4	Q9NNZ3	11	64230278-64234286	Predicted intracellular proteins, Predicted membrane proteins		Chaperone		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Low tissue specificity	Detected in all			Cell type enriched	Detected in many	4	Late spermatids: 2560.6	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all			Low region specificity	Detected in all							HPA011947	Uncertain											HPA011947: AB_1847803	unprognostic (8.99e-3)	unprognostic (2.28e-2)	prognostic unfavorable (3.12e-4)	unprognostic (2.95e-2)	unprognostic (1.15e-1)	unprognostic (5.20e-2)	unprognostic (8.99e-2)	unprognostic (1.56e-2)	unprognostic (7.69e-2)	unprognostic (5.44e-3)	unprognostic (1.73e-3)	unprognostic (1.07e-1)	prognostic favorable (6.21e-4)	unprognostic (2.47e-1)	unprognostic (2.87e-1)	unprognostic (1.59e-1)	unprognostic (2.69e-1)	16.7	26.5	16.5	15.6	17.3	22.5	15.8	14.5	26.6	22.9	24.7	15.3	24.4	23.3	22.1	25.6	28.6	15.2	26.5	26.5	15	13.3	25.2	26.4	16.5	22.5	16.4	9.6	29.3	55.1	22.5	19.5	14.7	19	28.7	14.1	19.7	50	22.8	31	19.1	28.2	13.7	15	28.1	18.9	72.5	8.6	26.4	33.2	18	28.7	22.9	20.3	18.8	46.6	14.8	20.6	14.5	12.2	12	4.5	4.4	10.4	15.3	12.7	22.3	7.3	6.7	11.5	4.2	5.8	4.3	6.7	5.5	22.5	12	2.5	3.6	5.1	6.1	2.4	11.6	6	6.9	4.5	11.7	15.4	5	16.4	23.1	16.5	6.6	7.8	20.1	9.9	6.2	4.6	29.3	2.7	11.2	2	12.2	2.9	10.8	8.5	14.3	2.7	36.9	17.4	3.1	9	14.7	6.8	7.7	25.2	10.4	18.7	9.2	9.1	4.9	4.9	7.4	3.8	29	11.6	6.7	4.3	6.4	14	14.8	20.6	14.6	8.3	18.2	10.5	17.5	8.4	9.7	28.7	18.8	12.2	9.4	11.4	14.5	14.4	46.6	7.8	12	16.5	17.3	14.5	26.6	15	13.3	16.4	9.6	19	8.6	11.9	32.8	67.7	44.8	38.8	19.6	20.4	22.9	14.7	23.9	26.2	7.9	65.2	135.9	28.7	574	28.9	54.9	0	33.4	50.6	35	55.4	46.1	29.9	46.7	23.8	78.1	30.7	62.3	2560.6	58.1	54.9	45.5	123.6	63.7	20.3	28	59.6	43.9	75.2	13.6	19.4	29.9	26	24.9	44.7	45.5	42.7	59.3	49.1	Late spermatids
GSG1	MGC3146	ENSG00000111305	Germ cell associated 1	Q2KHT4	12	13083560-13103683	Predicted intracellular proteins, Predicted membrane proteins, Transporters				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	60	testis: 156.4	Cell type enriched	Detected in many	5	Late spermatids: 9027.4	Cancer enhanced	Detected in single		testis cancer: 1.9	Not detected	Not detected			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		fHDF/TERT166: 9.6;LHCN-M2: 11.0;RPTEC TERT1: 13.7;U-2 OS: 6.9	Not detected	Not detected			Not detected	Not detected								Intracellular and membrane								unprognostic (1.50e-1)	unprognostic (2.21e-2)		unprognostic (6.33e-2)	unprognostic (2.36e-2)	unprognostic (1.34e-1)	unprognostic (8.01e-2)	unprognostic (1.04e-1)	unprognostic (4.52e-1)	unprognostic (6.85e-2)	unprognostic (8.23e-2)	unprognostic (5.91e-2)	unprognostic (3.20e-3)	unprognostic (1.48e-1)	unprognostic (3.65e-2)	unprognostic (1.79e-1)	unprognostic (6.32e-3)	0	0	0.1	0	0.1	0.1	0	0	0.2	0	1.3	0	0	0.3	0	1.6	0	0	0	0	0.1	0.1	0.1	0	0	0	0.1	0	0	1.4	0	0	0.2	0.2	0	0	1.8	0	0	0	0	0.5	0	0.1	0	0	156.4	0	0	0	0	0	0	0	1.3	0.7	2.6	0.7	0.5	1.2	0.1	0.1	0.5	0.3	0.1	2.3	1.4	0.5	0.2	0.4	0.4	0.5	0.2	0.1	0.2	0.2	9.6	0.8	0.1	0.2	0	0.9	0.2	0	0.2	0.6	0.3	0	0.2	0.1	0.9	0	1.8	0.1	0.1	0	0.1	0.1	1.8	11	0.3	0.1	1.1	2.3	0.1	0.2	0.1	4	0.2	13.7	0.2	0.6	0.3	0.2	0	0.1	0.3	0.1	1.6	0.1	0.6	6.9	0.3	0.3	0.6	0.4	0.1	3	0.3	0.2	1.3	0.5	0.9	1.2	0.4	0.6	0.8	0.6	1	0.4	1.3	0.8	0.9	2.6	0.5	0.7	0.7	0.5	0.1	0.1	0.1	0	0.2	0.1	0.1	0.1	0	0.2	0	3	1.4	0	0.1	0.1	9.4	0.4	0	0	0	0	5.9	0.1	1.7	0.4	1969	0	0	23.3	0	0.1	0	0.1	0	0	0.7	1.6	26.4	2.5	0	9027.4	49.5	0	0	0	0	5.7	0	0	37.4	0	14.7	6.5	0	51.2	19.7	0	0	0	0	0	Late spermatids
REEP6	C19orf32, DP1L1, FLJ25383, Yip2f	ENSG00000115255	Receptor accessory protein 6	Q96HR9	19	1490747-1497927	Disease related genes, Predicted membrane proteins			Disease mutation, Retinitis pigmentosa	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		intestine: 90.8;liver: 119.0;testis: 71.2	Cell type enriched	Detected in many	5	Late spermatids: 2546.7	Cancer enhanced	Detected in all		liver cancer: 114.0	Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		CACO-2: 16.1;Hep G2: 15.4;K-562: 42.7;T-47d: 35.7	Not detected	Not detected			Low region specificity	Detected in many			HPA003895, HPA048015	Enhanced		Supported	Endoplasmic reticulum					26000	Endoplasmic reticulum		HPA003895: AB_1845723, HPA048015: AB_2680233	unprognostic (1.21e-1)	unprognostic (1.56e-1)	unprognostic (7.76e-2)	unprognostic (1.63e-3)	unprognostic (3.24e-1)	unprognostic (2.43e-2)	unprognostic (1.92e-1)	unprognostic (6.85e-2)	unprognostic (7.38e-2)	unprognostic (4.56e-1)	unprognostic (1.49e-1)	unprognostic (1.93e-1)	unprognostic (1.40e-2)	unprognostic (2.17e-1)	unprognostic (8.08e-2)	unprognostic (2.83e-1)	unprognostic (5.38e-2)	2.4	20.1	4.1	0.7	5.9	0.6	3.9	3.1	6	1.4	41.7	2.8	4.4	60.2	1	5.7	2.7	1.4	7.6	0.9	4.5	1.9	6.1	119	0.6	0.7	2.6	2.1	1.7	10.1	0.5	2.2	0.7	2.1	4.9	0.7	27.4	5.6	11.8	0.7	1.7	90.8	1.1	1.6	0.6	1.3	71.2	1.1	0.3	1.6	1.1	2.1	3.2	1.2	1	4.2	0.1	4.8	5.8	7.1	2.3	2	2.5	0.8	10.5	1.6	0.5	11.7	0.5	0.1	0.5	0.5	16.1	6.6	1.1	3.7	0.3	0.7	2.1	2.7	0.1	0.2	0.5	1.1	6.1	0.3	15.4	1.2	0.4	2	1.3	1.1	0	0.3	0.9	0.3	1.4	42.7	1.5	0.1	8.1	0.5	1.3	3.9	5.9	5.7	1.6	0.3	2.7	3	0.9	0.2	5.8	2.8	4.1	1.7	0.4	35.7	1.6	0.9	0.8	1.7	2.5	0.4	5.1	1.4	0.1	3.6	2.6	2.3	0	1.5	0	7.1	1.7	3.8	0.1	2.1	1.5	2.5	1	2.8	3.2	0.1	5.8	4.8	4.2	2	2.3	4.1	5.9	3.1	6	4.5	1.9	2.6	2.1	2.1	1.1	3	2.7	3.4	6.8	6.1	23.2	1.6	86.6	5.3	6.8	5.2	31.4	55	6.6	28.9	512.6	2.8	17	0	61.1	7.5	2.5	15.7	10.3	229.1	8.2	22.3	5.8	4.3	5.7	2546.7	31.7	4.3	28.7	1.8	10.4	27.6	24.6	6	15.6	36	217.9	19.4	2.6	24.2	30.4	5.8	30.1	5.1	11	11.2	Late spermatids
ERI3	FLJ22943, PINT1, PRNPIP	ENSG00000117419	ERI1 exoribonuclease family member 3	O43414	1	44221070-44355260	Predicted intracellular proteins		Exonuclease, Hydrolase, Nuclease		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	4	Late spermatids: 823.2	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all			Low region specificity	Detected in all							HPA027147, HPA029895	Approved		Approved	Nucleoplasm,Cytosol		Yes	No			Nucleoplasm, Cytosol		HPA027147: AB_1855725, HPA029895: AB_2673239	unprognostic (1.31e-1)	unprognostic (2.39e-2)	unprognostic (3.26e-1)	prognostic unfavorable (1.18e-4)	unprognostic (5.94e-2)	unprognostic (6.21e-2)	prognostic unfavorable (2.04e-6)	unprognostic (6.48e-2)	unprognostic (2.67e-1)	unprognostic (6.70e-3)	unprognostic (5.30e-2)	unprognostic (2.49e-1)	unprognostic (1.49e-2)	unprognostic (2.07e-1)	unprognostic (7.47e-2)	unprognostic (1.08e-1)	unprognostic (2.07e-3)	12.6	15.4	30.7	8.3	32	12.4	15.2	19.7	43.7	15.1	13.4	23.2	10.8	12.3	14.7	22.2	13.4	23.4	12.7	21.1	28.9	25.1	25.3	15.5	11.7	10	23.9	26.8	18.6	15.7	24	17.2	13.5	22.9	16.7	14.1	14.8	14.7	16.9	35.7	13.3	8.6	17.7	17.9	9.5	10.6	24.4	21.9	9.7	17.6	11.9	11	12.5	12.1	18.8	25.3	9.6	22.2	14.8	18.2	15.2	28.6	22.2	28.2	31.2	18.5	23.3	17.7	18.8	25	33.4	31.2	14.3	30.7	20.5	31.8	23.1	17.1	16.6	25.2	32	23.6	22.9	48.6	22.9	37.5	20.2	27.1	23.1	13.2	23.7	30.1	25.3	34.8	24.8	22.9	22.9	22.3	16.7	21.9	19.3	25.6	21.6	33.4	25.5	35.2	24.7	25.9	30	25.9	15.1	48.1	22.7	20.5	28.1	33.2	23.3	18.4	19.1	13.9	22.1	23.1	24	28.4	15.9	18.5	22	27.4	20.1	27.8	9.4	16.3	9.6	16.7	22.2	18.2	18.8	14	16.2	25.3	18.3	16.7	17.2	1.5	14.8	21.3	18.9	18.1	15.2	30.7	32	19.7	43.7	28.9	25.1	23.9	26.8	22.9	21.9	23.8	16.8	23.4	29.6	28	20.9	13.7	10.2	10.7	9.1	27.9	2	80	82.9	48.6	192.5	20.2	20	0	54.5	67.1	42.9	35.8	15	21.3	39.5	23.8	113.7	19.6	24.3	823.2	33.6	22.4	45.5	35.1	48.9	30.3	33	25.9	34.3	131.8	13.5	6.5	31.1	46.2	48.7	30.2	51.5	15.4	35.1	23.5	Late spermatids
TREH	MGC129621, TRE, TREA	ENSG00000118094	Trehalase	O43280	11	118657316-118679690	Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins		Glycosidase, Hydrolase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	8	intestine: 51.8	Cell type enriched	Detected in some	6	Late spermatids: 233.7	Low cancer specificity	Detected in some			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BEWO: 5.4;Hep G2: 2.1;RPMI-8226: 1.9;SiHa: 1.8;SK-MEL-30: 1.5;U-2 OS: 2.5	Not detected	Not detected			Low region specificity	Detected in some			HPA039913, HPA042045	Enhanced				Intracellular and membrane				12000000			HPA039913: AB_10674988, HPA042045: AB_2677817	unprognostic (1.29e-1)	unprognostic (1.58e-1)	unprognostic (1.01e-2)	unprognostic (5.22e-4)	unprognostic (2.52e-1)	unprognostic (9.83e-2)	prognostic favorable (3.76e-4)	unprognostic (1.17e-1)	unprognostic (1.34e-1)	unprognostic (2.42e-1)	unprognostic (1.04e-1)	unprognostic (1.63e-2)	prognostic favorable (2.33e-6)	unprognostic (2.09e-2)	unprognostic (6.30e-2)	unprognostic (1.22e-1)	unprognostic (1.15e-1)	0.1	0.1	0.1	0.2	0.1	0	0.1	0.2	0.1	0.1	24.1	0	0	28.9	0.1	3.3	0.6	0.1	3.7	0.1	0.1	0.1	6.1	2.6	0.1	0	0.1	0	0.1	0.5	0	0.1	0	0.1	0.2	0.4	0	0.2	0	0.1	0.1	51.8	0	0.1	0.1	0.6	0.3	0	0	0.1	0	0.3	0.1	0.1	0	0.5	0	0	0	0	0.1	0	0	0.2	0	0.1	0.3	5.4	0	0	0	0	0.8	0.7	0	0.5	0	0	0.1	0	0	0	0	0.1	0	0	2.1	0	0	0.1	0	0	0	0.1	0	0.2	0	0	0	0	0.1	0	0.3	0.1	0	0	0	0.1	1.9	0	0	0.2	0.9	1.8	0.3	1.5	0.1	0.7	0	0.8	0.1	2.5	0.4	0.2	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0	0.1	0	0	0	0	0.7	0	0	0	0	0	0	1.8	0	0	6.6	0.1	37.2	0	2.9	0	2.3	0	0	0.2	0	0	0.1	0	2.9	0	0	233.7	2	0	0	0	0.9	0	0.6	5.8	1.8	16.5	0	0	0.1	1.8	0.8	0	0	0	1.2	0	Late spermatids
PRM2	CT94.2	ENSG00000122304	Protamine 2	P04554	16	11275639-11276480	Predicted intracellular proteins	Differentiation, DNA condensation, Spermatogenesis	Developmental protein, DNA-binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	99	testis: 699.5	Cell type enriched	Detected in some	5	Late spermatids: 355121.5	Cancer enriched	Detected in single	187	testis cancer: 11.0	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	8	BEWO: 3.5;NB-4: 3.8;U-2197: 5.7									CAB032738, HPA056386	Enhanced											CAB032738: AB_2171312, HPA056386: AB_2683111															unprognostic (3.88e-2)			0	0	0	0	0	0	0.2	0	0.3	0	0	0	0.3	0	0	7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0	0	0	0	699.5	0	0.1	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	3.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.8	0	0	0	0	0	0	0	0	0.5	0.2	0	0	0	0	0	0	0	0	0	5.7	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	67214.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	355121.5	1424.2	0	0	0	0	0	0	0	1572.7	0	0	899	0	1873	751	0	0	0	0	0	Late spermatids
PSPN	PSP	ENSG00000125650	Persephin	O60542	19	6375148-6379058	Predicted secreted proteins		Growth factor		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Low tissue specificity	Detected in all			Cell type enriched	Detected in many	5	Late spermatids: 18.9	Low cancer specificity	Detected in all							Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all			Not detected	Not detected			Low region specificity	Detected in some			CAB025366	Uncertain				Secreted in other tissues							CAB025366: 	unprognostic (3.21e-1)	unprognostic (3.36e-2)	unprognostic (1.12e-1)	unprognostic (1.52e-2)	unprognostic (3.67e-1)	unprognostic (2.05e-2)	unprognostic (5.80e-3)	unprognostic (1.14e-1)	unprognostic (1.69e-1)	unprognostic (6.27e-2)	unprognostic (1.54e-6)	unprognostic (5.39e-3)	unprognostic (1.01e-3)	unprognostic (4.25e-2)	unprognostic (2.26e-1)	unprognostic (2.44e-1)	unprognostic (1.60e-1)	1	1.7	2.5	1.1	2.7	1.6	1.1	6.4	3.4	1.8	1.4			1.1	1.6	3.5	1.3	2.5	1.3	1.1	2.3	2.1	2.5	2.2	1.1	1.2	1.5		2.8	1.6	2.7	2.4	1.1		1.8	1.5		1.8	1.6	1.3	1.7	1.8	1.4	0.8	1.9	1.5	1.5			2.5		1.5	1.1	1	2.6	2.8	4.6	2.6	1.8	3	1.6	1.6	3.8	2.2	5.5	5.1	3.4	1.2	1.9	1.9	2.1	2.3	3.7	1.4	2	3.1	2.4	1.9	2.4	3.7	1.4	2.4	3	2.9	2	2.2	2.9	3.7	1.6	2.9	4	4.3	1.7	2.8	5.7	1.4	3.2	2.4	2.5	2.4	2.9	3.7	3.3	2.2	3.8	4.3	3.2	2.6	1.3	3.5	2.2	3	4.6	3.2	3	2.5	3	3.4	1.9	1.8	2.7	2.6	4.7	1.2	4.4	7	1.1	5	3.3	2.6	4.6	2.1	1.8	2.1	1.6	3	2	1.5	2.6	1.2	2.6	2.3	2.3	3.6	1.8	2.6	2.8	1.7	1.6											0	1.7	0	0.8	0.6	1.8	1.5	0	0	0	1.8	0	0.8	0	1	3.6	1.2	4.1	0	0.2	0.6	1.3	1.4	1.1	2.6	1.8	1.6	2.9	1.8	2.2	18.9	0.9	0.2	1.7	1	2	1.5	1.1	2.9	2.1	2.2	1.8	0	0.9	1.4	0.7	0.9	1.1	0.5	2.4	0.9	Late spermatids
TMEM53	FLJ22353, NET4	ENSG00000126106	Transmembrane protein 53	Q6P2H8	1	44635238-44674555	Predicted intracellular proteins, Predicted membrane proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		blood: 38.7;liver: 44.7	Cell type enriched	Detected in all	5	Late spermatids: 845.8	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enriched	Detected in many	4	plasmacytoid DC: 38.7	Lineage enriched	Detected in all	4	dendritic cells: 38.7	Low cell line specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA021134	Approved		Approved	Golgi apparatus,Focal adhesion sites						Golgi apparatus	Focal adhesion sites	HPA021134: AB_2205162	unprognostic (5.28e-2)	unprognostic (2.60e-1)	unprognostic (5.37e-2)	unprognostic (4.62e-2)	unprognostic (3.93e-2)	unprognostic (1.14e-1)	unprognostic (2.82e-2)	unprognostic (2.88e-2)	unprognostic (2.19e-2)	prognostic favorable (6.96e-4)	unprognostic (3.00e-1)	unprognostic (1.34e-1)	prognostic favorable (1.02e-5)	unprognostic (1.15e-3)	unprognostic (1.84e-2)	unprognostic (4.07e-2)	unprognostic (2.29e-2)	8.3	9	6	4.4	8.7	6	7	2.4	11.8	4.9	11	8.8	4.6	16.6	5.7	7.2	4.5	5.3	7.6	9.3	6.2	6.1	14.8	44.7	7.3	6.4	6.8	6.2	7.7	5.4	3.3	6.4	4.3	8	5.2	7.2	13.9	6	3.8	4.2	3.9	16.4	4.5	6.1	4.8	7.7	18.8	4.4	3.6	8.2	3.1	4	7.3	3.7	5.3	38.7	3.6	8.6	2.8	3.1	2.8	7.6	8.8	8	5.8	10.4	7.9	9.6	2.2	6.7	4.4	6.6	2.8	24.2	2.4	7.3	2.1	17	6.9	2.2	4.7	2.3	3.8	5.6	2.8	3.6	13.4	10.4	2.2	10.3	9.3	7.3	8.8	1.9	4.8	2.4	5.5	1.2	3.1	2.6	4.5	2.5	6.5	4.6	5.9	5.2	4	1.1	23.6	13.1	8	5.6	5.4	2.4	9.6	12.4	5.9	3	5.8	1	3.2	5.5	4.6	2.8	2.2	2.6	1.3	8.4	5.7	3.7	3.6	5.2	2.3	3	8.6	2.6	5.3	3.1	2.5	2.6	5	1.5	2	0.5	2.8	6	38.7	3	2.8	6	8.7	2.4	11.8	6.2	6.1	6.8	6.2	8	4.4	6	11.8	2.4	6.7	1.4	5.6	24.6	10.2	18.7	9.1	19.2	3.9	11.6	38.1	14.3	155.5	8.7	50.1	23.3	22.5	13.2	5.6	7.8	5.8	81.3	29.8	17.5	13.8	8	8.3	845.8	8.3	7.2	8.5	1.8	18.4	12.9	16	56.1	11.7	39.8	12.4	25.8	7.3	5.1	8.3	1.9	7.8	4.1	15.4	10.3	Late spermatids
HIP1	ILWEQ	ENSG00000127946	Huntingtin interacting protein 1	O00291	7	75533300-75738962	Cancer-related genes, Disease related genes, Predicted intracellular proteins	Apoptosis, Differentiation, Endocytosis, Transcription, Transcription regulation	Actin-binding, Activator	Cancer-related genes, Neurodegeneration	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	5	Late spermatids: 1171.7	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		A549: 27.3	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA013606, CAB015334, CAB016402, HPA017964	Enhanced		Supported	Vesicles						Vesicles		CAB015334: AB_2117565, CAB016402: AB_627725, HPA013606: AB_1850717, HPA017964: AB_1850719	unprognostic (8.23e-2)	unprognostic (1.22e-1)	unprognostic (2.20e-2)	unprognostic (1.64e-1)	unprognostic (1.04e-1)	unprognostic (2.59e-1)	unprognostic (2.73e-3)	unprognostic (1.03e-2)	unprognostic (1.11e-2)	unprognostic (2.02e-2)	unprognostic (2.70e-2)	unprognostic (7.98e-2)	unprognostic (1.73e-3)	unprognostic (9.67e-2)	unprognostic (1.75e-1)	unprognostic (1.00e-2)	unprognostic (1.09e-1)	16.5	8.7	14.6	7.2	25.9	5.1	13.5	13.2	20.8	13.2	5.3	34.4	4.9	2.9	13.4	10.1	5.7	13.8	8.7	9.2	17.5	11.9	14.6	9.6	17.7	4.6	27.2	11.8	8.1	4	4.9	3.6	20	16.1	6.8	4.5	9.9	4	12.4	3.9	10.8	4.6	12.6	24.8	10.8	4.6	18.5	29.7	1.6	15.8	5.7	4.6	9.7	8.8	0.5	4	8.8	1.1	3.3	1.5	0.3	2.5	27.3	18.6	17.5	7.9	10.7	5.6	4.8	3.1	3.1	2.3	1.5	2.4	1.8	5.6	11.8	10.9	3.1	18.8	3.9	4.2	1.5	3.5	1.4	3.2	2.5	7.8	0.4	7.4	8.2	2.4	10.2	2.1	5.8	13	2	1.9	1.8	5	10.4	1.2	10.6	20.2	0.2	3.3	2.1	7.8	0.1	2.4	9.7	0.9	8.2	4.4	2.8	6.3	17.3	17.2	6.7	4.6	9.2	7.1	3.1	6.6	2	0.2	4.4	9.2	3.9	6.2	8.8	1.1	7.6	1.1	1.1	1	0.4	0.2	0.9	1.6	0.5	0.1	0.7	7.7	3.3	0.8	4	1.5	0.3	14.6	25.9	13.2	16.9	17.5	11.9	27.2	11.8	16.1	29.7	56.6	35.7	6	6.3	15.7	7.1	12.5	5.1	0	17	26.2	11.8	1.3	11.6	10.2	240.8	40.7	0.7	0	5.3	7.5	15.4	4	13.9	20.2	11.7	22.3	4.6	30.1	15.1	1171.7	20.8	22.9	10.1	1	1.4	18.6	2.6	8.5	23.3	2.2	8.2	84.1	37.2	9.3	4.1	8	0.7	17	2.6	3.1	Late spermatids
DGCR6L	FLJ10666	ENSG00000128185	DiGeorge syndrome critical region gene 6 like	Q9BY27	22	20314276-20320080	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	4	Late spermatids: 2083.4	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all																								unprognostic (1.91e-1)	prognostic favorable (3.82e-5)	unprognostic (2.74e-2)	unprognostic (4.61e-3)	unprognostic (3.97e-2)	unprognostic (2.46e-1)	unprognostic (2.61e-1)	prognostic favorable (5.37e-4)	unprognostic (1.44e-1)	unprognostic (4.39e-2)	unprognostic (3.29e-3)	unprognostic (9.07e-3)	unprognostic (6.72e-3)	unprognostic (4.37e-2)	unprognostic (2.91e-1)	unprognostic (1.26e-1)	unprognostic (2.97e-1)	12.2	14.4	25.4	8.5	24.2	15.2	15.1	14.8	26.2	16.2	12.4	13.4	17.7	11.7	10.9	19.4	14.3	18.2	15.8	25.6	21	18.1	16.7	41.7	13.3	24.1	18.1	17.7	16.1	27.1	12.4	13.6	10.4	15.1	15.4	6.8	15	26.9	18.8	41.8	19.2	13	17.2	13.4	11	12.3	45.7	11.7	13.1	18.1	17.3	11.6	11.2	10.6	28	33.2	49.1	37	45.6	49.8	39.3	12.8	14.6	10	25.1	14.6	14.7	10.5	12.5	14.8	23.2	17	7.5	6.3	3.4	16.5	13.6	9.3	13.1	7.4	15.1	3.8	16.7	38.3	8.3	10.2	13.8	17.5	17.8	8.4	16.5	13.9	9.2	9.7	8.9	16.2	16.5	37.7	15.4	14.8	29.8	13	15.8	7.3	25.4	21.9	23.5	23.2	6.6	12	10.1	20	14.7	20.6	13.5	22.9	4.4	19.6	14.2	12.5	27.7	32.5	14.7	12.2	13.8	14.6	7.8	22.3	22.2	18.5	32.3	37	49.1	39.9	31.9	39.5	28	49.8	44.2	33.2	25.9	47	44	12.3	45.6	30.3	30.9	44.2	39.3	25.4	24.2	14.8	26.2	21	18.1	18.1	17.7	15.1	11.7	26.8	27.5	37.6	30.6	38.8	18.2	68.3	35.7	36.1	29.6	33.2	3.9	60.6	112.7	63.6	484.3	41.6	60.3	0	55.1	69	54.6	29.9	39.2	139.4	71.5	27	50.7	47.3	62.7	2083.4	65	47	54	29.7	57.3	26.9	46	51.6	66.4	103.1	16.9	45.3	61.7	112.8	79.9	53.2	18.3	66	62.4	21	Late spermatids
TSPAN16	TM-8, TM4-B, TM4SF16	ENSG00000130167	Tetraspanin 16	Q9UKR8	19	11296139-11326996	Predicted membrane proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	14	blood: 21.8;testis: 46.1	Cell type enriched	Detected in some	5	Late spermatids: 4024.1	Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	10	basophil: 6.9;eosinophil: 10.8;neutrophil: 21.8	Lineage enriched	Detected in many	16	granulocytes: 21.8	Cell line enhanced	Detected in some		MCF7: 3.0;THP-1: 1.1;U-937: 3.0					Not detected	Not detected			HPA076551	Enhanced											HPA076551: 	unprognostic (1.06e-1)	unprognostic (2.82e-2)	unprognostic (1.73e-2)	unprognostic (4.74e-3)	unprognostic (1.53e-1)	unprognostic (2.06e-3)		unprognostic (1.37e-1)	unprognostic (2.21e-1)	unprognostic (7.68e-2)	unprognostic (1.90e-1)	unprognostic (8.69e-4)	unprognostic (8.81e-8)	unprognostic (1.98e-1)	unprognostic (1.12e-1)	unprognostic (1.95e-3)	unprognostic (2.67e-1)	0	0	0.2	0	0	2.5	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	46.1	0	0	0	0	0	0	0	0	0.3	21.8	1.3	0	0	0.1	0	0	0	0.4	0	0	0	0	0	0	0	0	0.2	0.1	0.1	0	0.1	0	0	0	0	0	0	0.4	0	0	0	0	0.3	0	0	0	0	0.2	0	0.1	0.4	0.7	0	3	0	0.9	0.3	0	0.4	0.1	0.2	0	0	0	0	0	0	0.2	0	0.2	0.6	1.1	0	0.2	0	0.2	0.1	0	0.2	0	0	3	0	6.9	1.3	10.8	0	0.5	0	0	0	0	0.3	0	0	0	21.8	0	0.2	0	0	0.1	0.2	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	2.2	0	0	0	0	0	0	0	0	855.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4024.1	14.4	0	0	0	0	0	0	0	15.2	0	0	6.5	0	18.6	10.1	0	0	0	0	0	Late spermatids
LPIN1	KIAA0188	ENSG00000134324	Lipin 1	Q14693	2	11677595-11827409	Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins	Fatty acid metabolism, Lipid metabolism, Transcription, Transcription regulation	Hydrolase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		skeletal muscle: 88.4	Cell type enriched	Detected in many	4	Late spermatids: 1310.7	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Cell line enhanced	Detected in all		U-266/70: 38.8	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA024591, HPA038021	Approved		Approved	Plasma membrane,Cytosol						Cytosol	Plasma membrane	HPA024591: , HPA038021: AB_10669514	unprognostic (1.97e-1)	unprognostic (2.47e-1)	unprognostic (1.32e-1)	unprognostic (1.87e-2)	unprognostic (9.17e-2)	unprognostic (2.69e-2)	unprognostic (8.20e-2)	unprognostic (5.28e-3)	unprognostic (1.09e-1)	unprognostic (1.07e-2)	unprognostic (2.45e-3)	unprognostic (2.55e-2)	unprognostic (1.06e-1)	unprognostic (5.58e-3)	unprognostic (1.25e-1)	unprognostic (9.60e-2)	unprognostic (4.02e-1)	18.1	10.1	13	10.7	18.3	6	22.1	20	16.4	10.5	8.6	10.9	7.3	8.9	11	15	20	7	10.4	12.8	11.6	11.9	7.6	13.2	8	15.4	13.2	11.2	19.3	7.5	17.2	32	9	17.9	9.6	7.1	9	14.4	11.6	88.4	6.5	9.2	11	10.3	8.4	7.6	39	13.2	8.3	8.1	14	19.2	10.4	21.7	6.5	9.6	11.6	2.8	8	11.1	3.2	5.5	6.6	5.5	12.3	25.5	28.4	2.8	7.8	13.4	5	8.7	2.4	5.5	2.7	1	6.6	14.8	6	6.2	17	4.6	11.4	3.4	6.8	3.7	3.5	9	4.7	32.1	25.6	7.7	20.8	7.9	14.7	9.7	6.7	9.4	24.7	3.7	2.1	4.4	4.1	5.7	1.8	6.7	6.1	10.1	17.3	12.7	3.6	15.3	12.1	2.8	6.8	17.5	5.5	1.7	2.6	6.8	8	7.2	5.1	6.7	38.8	30	5.2	11.3	8.4	5.9	9.5	2.8	11.6	10.3	2.1	11.1	6.5	9.6	9.7	2.5	5	8.4	7.1	1.1	8	2.1	9.6	10.5	3.2	13	18.3	20	14.4	11.6	11.9	13.2	11.2	17.9	13.2	20.8	49.1	22.9	38.9	16.9	40.6	49.5	25.5	61.6	63.7	10.4	80.5	7.3	6.6	18.7	314.7	24.6	9.7	0	24.2	5.3	24.6	29.2	33.6	21.9	8.1	46.1	34.7	15.4	15.7	1310.7	110.1	27.2	16.9	7.2	23.9	16.4	25.5	11.6	169	3.4	47.2	32.3	20.6	18.4	17.8	10.5	10.3	57.5	13.6	26.8	Late spermatids
MORN3		ENSG00000139714	MORN repeat containing 3	Q6PF18	12	121648742-121672631	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	7	placenta: 30.1;testis: 51.5	Cell type enriched	Detected in many	5	Late spermatids: 1766.8	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Group enriched	Detected in some	9	BEWO: 12.6;CACO-2: 6.8	Low region specificity	Detected in many			Low region specificity	Detected in many			HPA038709, HPA038710	Uncertain		Approved	Nucleoplasm						Nucleoplasm		HPA038709: AB_2676164, HPA038710: AB_2676165	prognostic favorable (1.16e-4)	unprognostic (2.70e-3)	unprognostic (5.56e-2)	unprognostic (5.13e-2)	unprognostic (7.38e-3)	unprognostic (3.46e-3)	unprognostic (7.44e-2)	unprognostic (3.70e-2)	unprognostic (4.31e-2)	unprognostic (3.09e-2)	unprognostic (3.65e-3)	unprognostic (3.11e-2)	unprognostic (1.39e-2)	unprognostic (3.06e-1)	unprognostic (2.21e-1)	unprognostic (8.85e-2)	unprognostic (1.18e-1)	0.3	0.2	1.2	0.5	1.4	0.9	0.3	0.3	1.6	0.4	0.3	0.3	0.3	0.2	0.3	1.4	0.3	5.6	0.4	0.3	1.4	1.2	0.4	0.3	1	1.4	0.3	0.3	0.3	0.4	3.4	0.7	30.1	0.3	0.3	0	0.3	0.3	0.3	0.3	2.5	0.3	0.3	0.3	0.8	0.8	51.5	0.3	0.3	0.5	0.3	0.6	0.3	0.3	1.2	1.2	3.1	0.6	2.2	2.3	0.6	0.1	0.2	0.4	0.2	0	0.3	12.6	0.2	0	0.1	0.1	6.8	0.3	0.2	0.2	0.1	0.2	0.4	0.1	0.1	0.1	0.1	0.1	0.5	0.3	0.4	0.3	0.4	0.9	0.1	0.3	0.3	0	0.1	0.2	0.8	0.2	0.3	0.1	0.2	0.8	0.6	0.2	0	0.1	0.3	0	0.1	0.4	0.2	1.1	1.1	0.1	0.2	0	0.5	0.9	0.1	0.1	0.2	0.2	0.3	0.1	0.2	0.1	0.4	0.9	0.3	0.1	2.3	0.6	0.4	2.1	0.3	2	0.8	2.3	1.3	0.2	1.2	2.1	1.4	3.1	2.2	0.5	1.2	2	0.6	1.2	1.4	0.3	1.2	1.4	1.2	0.3	0.3	0.3	0.3	3	2.2	0.5	1.1	2.9	1.1	1.1	5.1	50.9	11.4	1.8	0	0.2	6.6	3.3	357	1.5	0	0	1.2	0.4	1.3	0.3	2.3	0	0.8	0	0	0.6	0	1766.8	8.6	0.1	0	1.8	0	3.7	1.7	0	8.9	0.8	1.7	0	0	7	5.6	3.4	6.1	3.3	0.1	1	Late spermatids
BCAS3	FLJ20128	ENSG00000141376	BCAS3, microtubule associated cell migration factor	Q9H6U6	17	60677453-61392838	Disease related genes, Plasma proteins, Predicted intracellular proteins	Angiogenesis, Transcription, Transcription regulation		Proto-oncogene	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	4	Late spermatids: 203.3	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Cell line enhanced	Detected in all		MCF7: 43.3	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA052409, HPA057289	Approved		Approved	Nucleoli						Nucleoli		HPA052409: AB_2681821, HPA057289: AB_2683399	unprognostic (2.84e-2)	prognostic favorable (2.04e-4)	unprognostic (1.20e-1)	unprognostic (3.52e-1)	unprognostic (5.52e-1)	unprognostic (3.60e-2)	unprognostic (5.69e-2)	unprognostic (1.39e-1)	unprognostic (1.20e-1)	unprognostic (2.47e-1)	prognostic favorable (1.23e-5)	unprognostic (2.55e-1)	prognostic favorable (1.73e-5)	unprognostic (1.49e-1)	unprognostic (2.54e-1)	unprognostic (1.12e-1)	unprognostic (2.32e-1)	12.1	15.9	13.9	8.3	24.1	8.8	11.6	21.5	30.8	12.9	11.4	32.2	12.6	7.1	20.6	18.6	14.3	21.1	11.3	11.7	15.8	14.3	17.1	18.3	13.6	8.5	19.2	18.6	11.9	13.5	26.5	16.9	14.7	24.3	17.1	9.3	16.1	13.6	14.3	20.3	17	8.4	13.6	16.3	10.8	11.7	20.2	20	16.6	13.7	7.6	13.9	17	11.9	9.1	6.9	26.8	8	11.7	12.9	6.4	3.3	8.2	4.2	14.1	8.6	7.3	4.9	3.5	4.8	3.6	4.6	5.5	7.4	1.3	6	5.9	5	2.6	2.4	2.9	4.7	3	9.4	3.2	4.6	5	4.8	1.6	2.8	8.6	3.4	3	5.5	7.2	4.2	5.1	2.7	6.6	3.2	43.3	4.6	1.2	4.4	16.2	9.3	5.7	5.7	6	3	12.7	6.3	5.3	7.1	2.1	5	14.8	7.7	2.4	3.9	4.8	4.1	2	1.6	15.4	12.7	5.6	5.7	1.2	3.7	15.8	7.8	11.7	12.1	6.7	9.8	9.1	8.4	9.2	6.9	8.4	9.3	7.5	26.8	11.7	8	4.9	12.9	6.4	13.9	24.1	21.5	30.8	15.8	14.3	19.2	18.6	24.3	20	6	12.2	2.7	7.8	4.5	13	11.2	5.1	48.2	12.5	15.7	9.8	5.9	8.3	3.6	38.8	8.5	3.6	0	3.1	4.3	5	3.6	16.1	8.6	3.7	3.2	6.9	12.9	5.6	203.3	6.9	4.7	1.7	7.2	4.6	30.3	3.2	4.8	19.8	23	13.4	12.9	14.4	11.1	4.7	4.8	6.3	11.8	2.6	6.9	Late spermatids
OAZ3		ENSG00000143450	Ornithine decarboxylase antizyme 3	Q9UMX2	1	151762899-151771334	Predicted intracellular proteins	Polyamine biosynthesis			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	20	testis: 102.2	Cell type enriched	Detected in many	4	Late spermatids: 9340.9	Low cancer specificity	Detected in many			Not detected	Not detected			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low cell line specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			HPA030136, HPA045808			Enhanced	Nucleoplasm						Nucleoplasm		HPA030136: AB_2673331, HPA045808: 	unprognostic (2.12e-1)	unprognostic (3.86e-1)	unprognostic (1.53e-1)	unprognostic (5.44e-3)	unprognostic (1.71e-1)	unprognostic (1.01e-2)	unprognostic (1.48e-3)	unprognostic (1.08e-1)	unprognostic (1.73e-2)	unprognostic (1.01e-4)	unprognostic (1.57e-2)	unprognostic (2.89e-1)	unprognostic (8.05e-6)	unprognostic (3.94e-2)	unprognostic (1.32e-1)	unprognostic (2.50e-2)	unprognostic (8.36e-2)	0.4	0.3	0.5	0.7	0.5	0	0.6	0.6	0.6	0.3	0.4	0.4	0.7	0.1	0.3	2	0.4	0.2	0.3	0.6	0.5	0.5	0.5	0.8	0.6	0.8	0.5	0.5	0.3	0.6	1.4	0.6	0.3	0.4	4	0.5	0.3	3.1	0.7	1	0.3	0.3	0.5	0.6	0.6	0.2	102.2	0.2	0.3	0.8	0.7	0.4	0.4	0.6	1.4	3.2	2.2	5	2.6	2.4	1.6	1.2	2.3	1.4	3.3	1.1	3.3	2.9	2.3	0.6	2.2	1	1.3	3.1	1	2	0.7	1.6	1.2	1.3	2.3	0.7	7.3	6.9	1.1	4.4	1.8	1.3	0.6	1.3	5.1	1.4	2.6	3.5	1.4	3.4	3	1.4	3.7	2.3	9.7	0.9	1.6	3.3	4.6	2.5	0.4	1.1	1.7	0.4	2.9	1.5	3.6	1	5.2	4.6	3.2	10.4	2.7	3	1.3	0.7	2.6	1.3	5.1	9.5	2.6	1.7	1.6	3.5	2.2	3	0.6	1.4	1.5	1.3	1.4	1.3	2.4	3.2	1.2	1.5	2.2	2.1	2.6	5	1.3	2.2	1.6	0.5	0.5	0.6	0.4	0.5	0.5	0.5	0.5	0.4	0.2	0	1.7	0	2.1	0.7	0.6	1.2	0	2.7	1.2	0	2	1.4	1.7	1.8	2210.4	2.7	3	0	2.7	2.3	1.1	27.3	1.1	2.6	4	0	3.5	1.8	4	9340.9	42.6	1.1	1.7	2.8	7.2	1.6	2.5	4.2	40	2.8	1.6	0	0.8	57.9	27.9	0.5	1.3	0	1.8	3.1	Late spermatids
CRNN	C1orf10, SEP53	ENSG00000143536	Cornulin	Q9UBG3	1	152409243-152414263	Predicted intracellular proteins			Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		esophagus: 459.6;lymphoid tissue: 187.9;tongue: 139.6	Cell type enriched	Detected in single	6	Late spermatids: 2.2	Group enriched	Detected in many	18	cervical cancer: 19.3;head and neck cancer: 74.0;stomach cancer: 22.9	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		Daudi: 2.9;HaCaT: 1.1;HL-60: 1.2;hTCEpi: 1.0;K-562: 2.1;TIME: 1.2;U-266/84: 1.1;U-698: 1.5;U-937: 1.8	Not detected	Not detected			Low region specificity	Detected in many			HPA024343, CAB026182	Enhanced								36000			CAB026182: , HPA024343: AB_1847162		unprognostic (1.96e-2)		unprognostic (1.74e-6)		unprognostic (4.20e-2)			unprognostic (3.43e-1)	unprognostic (6.43e-3)								0.2	0.2	0	0.2	0	0.2	0.2	0	0.2	57.1	0.2	0	0	0.2	6.2	0.2	459.6	0.2	0.3	0.3	0	0	0.2	0.2	0.2	0.2	0	0	0.2	0.2	0.2	0	0.2	0	0.2	0.2	0	49.6	0.2	0.2	0.6	0.2	0.2	0	0.2	0.2	0.2	0	0	0.2	139.6	187.9	0.3	81.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.9	0	0	0	1.1	0	0	0	0	0	0.9	0	0	0	1.2	0	0	1	0	0	0	0	0	2.1	0	0	0	0	0	0.4	0	0	0	0.6	0	0	0	0	0	0.1	0	0	0	0	0	1.2	0	0.1	0	0	0	1.1	1.5	0	1.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Late spermatids
TMC2	C20orf145, dJ686C3.3	ENSG00000149488	Transmembrane channel like 2	Q8TDI7	20	2536607-2641784	Predicted membrane proteins	Ion transport, Transport	Ion channel		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in some		brain: 8.1;pituitary gland: 3.2	Cell type enriched	Detected in some	6	Late spermatids: 9.5	Not detected	Not detected							Cell type enhanced	Detected in single		gdT-cell: 1.4	Lineage enhanced	Detected in single		T-cells: 1.4	Cell line enhanced	Detected in single		ASC diff: 3.2	Not detected	Not detected			Low region specificity	Detected in single																unprognostic (4.73e-2)	unprognostic (1.87e-1)	unprognostic (5.88e-2)	unprognostic (8.30e-4)	unprognostic (2.86e-3)	unprognostic (3.00e-1)	unprognostic (1.13e-2)	unprognostic (1.07e-2)	unprognostic (4.54e-1)	unprognostic (1.41e-2)	unprognostic (4.05e-5)	unprognostic (2.90e-1)	unprognostic (3.21e-7)	unprognostic (2.47e-2)	unprognostic (2.56e-1)	unprognostic (1.93e-1)	unprognostic (5.74e-2)	2.3	0.4	0.3	0.3	0.8	0	0.7	8.1	0.4	0	0			0.4	0	0	0.2	0.2	0.9	0	0.2	0.9	0	0	3	0.2	0.1		0.5	0.1	0.1	3.2	0.1		0	0.1		0.3	0	0.1	0.2	0.1	0.1	0.1	0.2	0	2.5			0.2		0	0.8	0	0	0	0	0	0.3	1.4	0.1	0.2	0.4	0.3	0.2	3.2	0.9	0	0	0	0	0	0	0.3	0.3	0	0	0.2	0.4	0	0	0	0.3	0	0	0	0.2	0.3	0.1	0	0	0	0	0	0	0	0.3	0.1	0	0	0	0.2	0	0.1	0	0	0.1	0	0.3	0	0	0.1	0.1	0.1	0	0	0.4	0	0	0	0	0	0.1	0	0.1	0	0	0	0	0.2	0	0	0	1.4	0	0	0	0	0	0	0	0	0.3	0	0.3	0	0	0	0.1											0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	1.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	9.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	Late spermatids
OOSP2	FLJ36198, PLAC1L, TMEM122	ENSG00000149507	Oocyte secreted protein 2	Q86WS3	11	60040275-60048044	Predicted intracellular proteins, Predicted secreted proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	15	testis: 48.6	Cell type enriched	Detected in single	4	Late spermatids: 3.8	Not detected	Not detected			Not detected	Not detected			Cell type enriched	Detected in single	32	basophil: 3.2	Lineage enriched	Detected in single	32	granulocytes: 3.2	Not detected	Not detected							Not detected	Not detected			HPA050914	Enhanced				Secreted in male reproductive system							HPA050914: AB_2681271																		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	48.6	0	0	0	0	0	0	0	0	0	3.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0.4	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0.3	0	0	0	0	0	0.6	0	0	0	0	0	0	0	3.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.8	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0.4	0	0	0	0	0	Late spermatids
SH3RF2	FLJ23654, Hepp1, POSHER, PPP1R39, RNF158	ENSG00000156463	SH3 domain containing ring finger 2	Q8TEC5	5	145936579-146081791	Enzymes, Predicted intracellular proteins	Ubl conjugation pathway	Protein phosphatase inhibitor, Transferase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		gallbladder: 40.8	Cell type enriched	Detected in many	5	Late spermatids: 7204.3	Low cancer specificity	Detected in many			Group enriched	Detected in many	6	basal ganglia: 11.5;cerebral cortex: 2.9	Low cell type specificity	Detected in some			Group enriched	Detected in many	4	dendritic cells: 1.4;T-cells: 1.6	Cell line enhanced	Detected in many		CACO-2: 34.6;GAMG: 15.3;hTERT-RPE1: 17.2	Region enriched	Detected in single	14	basal ganglia: 23.9	Region enhanced	Detected in some		basal ganglia: 14.5	HPA035903, HPA058119	Uncertain		Enhanced	Nucleoplasm			Yes			Nucleoplasm		HPA035903: AB_10696515, HPA058119: AB_2683611	unprognostic (8.90e-3)	unprognostic (2.00e-3)	unprognostic (5.11e-3)	unprognostic (1.66e-2)	unprognostic (1.45e-3)	unprognostic (1.47e-2)	unprognostic (9.96e-3)	unprognostic (8.22e-2)	unprognostic (3.92e-1)	unprognostic (7.37e-3)	unprognostic (2.44e-3)	unprognostic (1.66e-1)	unprognostic (2.98e-2)	unprognostic (5.21e-2)	unprognostic (1.46e-1)	unprognostic (2.64e-2)	unprognostic (4.13e-3)	2.6	0.6	1.2	6.2	11.5	0	2.9	0.2	2.9	6.4	19.1	0.4	0.4	9.2	2.9	2.2	22.2	3.6	40.8	23.5	0.8	0.3	0.8	4.6	1.9	0	0.3	1.1	1	14.3	0	3.3	0.3	0.1	2.2	8.5	0.9	16.9	1	21.7	33.1	21.4	1.2	0.5	0.2	11.9	6.4	0.6	0.6	3.8	19.6	16.1	0.9	10	0	1.4	0.3	0.1	0	1.6	0.3	10.2	2.8	0.1	0.6	0	0	0	0.1	0.8	2.1	0.8	34.6	9.5	0	5.4	0.4	15.3	9.5	0	11.2	2	0.1	0.1	0	4.1	4.6	0.6	0	0	0.1	6	3.2	7.6	17.2	0.1	0.2	0	0	0.9	0	0	0	0.8	8.5	0.7	0	0.1	0	4.4	1	0	0	0.6	0.2	0.2	0.5	3.3	0	4.9	0.4	8.9	0.7	3.3	0	0	0	5.5	0	0	0.3	0	0	1.2	0	0	0	1.6	0.7	1.4	0	0	1.5	0.2	0	0.1	0	0.8	0.3	1.2	11.5	0.2	2.9	0.8	0.3	0.3	1.1	0.1	0.6	14.9	2.9	0	4.5	48.9	0.6	414.9	2.5	2.7	2.3	1.8	0	0	0	6.5	1412.5	1.5	27.7	0	7.6	0	0.5	1.3	1.1	8.3	0.2	0	1.2	0.6	0	7204.3	23.9	0	8.5	1	12.2	1.9	13.6	17.5	32.5	0.6	0	12.9	1.4	32	16.2	43.7	0	0	27.1	6.4	Late spermatids
CLPB	ANKCLB, FLJ13152, HSP78, SKD3	ENSG00000162129	ClpB homolog, mitochondrial AAA ATPase chaperonin	Q9H078	11	72285495-72434680	Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins		Hydrolase	Cataract, Disease mutation, Epilepsy	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in all	5	testis: 87.9	Cell type enriched	Detected in many	4	Late spermatids: 4145.4	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in many		myeloid DC: 18.3	Low lineage specificity	Detected in all			Low cell line specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA039005, HPA039006, HPA064571	Enhanced											HPA039005: AB_2676305, HPA039006: AB_10672767, HPA064571: AB_2685290	unprognostic (9.36e-2)	unprognostic (1.06e-2)	unprognostic (2.51e-1)	unprognostic (1.23e-1)	unprognostic (2.99e-1)	unprognostic (2.05e-2)	unprognostic (8.22e-2)	unprognostic (8.37e-2)	unprognostic (2.61e-1)	unprognostic (1.02e-1)	unprognostic (1.01e-2)	unprognostic (1.18e-1)	prognostic favorable (8.36e-8)	unprognostic (9.29e-2)	unprognostic (1.25e-1)	unprognostic (5.83e-2)	unprognostic (3.28e-2)	4.4	6.1	5.7	4.8	7.2	7.9	3.4	5.6	10.5	3.1	3.1	6.7	2.5	3.2	3.8	3.1	3.7	2.9	2.9	4.1	4.9	4.1	6.7	8.5	3.7	3	5.7	5.9	3.2	5.5	8.6	3.4	6.5	7.9	2.7	3.1	3.1	4.2	3.3	6.5	2.8	2.9	4.5	3.9	3.9	3.7	87.9	6.4	2.7	4.7	1.8	2.9	3.7	3	1.6	18.3	4	11.7	1.8	2.4	5.2	6.4	18.3	5.7	11.8	7.8	5.8	14.8	6.9	4.2	10.4	7.8	24.4	9.7	16.5	16	6.5	18.2	13.7	15.3	15.1	12.8	14.9	11.5	13.9	19	14.5	6.7	14	24.8	7.6	5	18.4	18.6	4.1	11.6	14.6	18.9	11.7	7.4	16.9	12.5	13.3	6	21.9	18.3	11.4	8.6	7.1	6	11	14.4	11	9.4	21.7	16.1	7.9	11.2	12.1	9.1	14.8	9.6	15	13.3	5.6	8	9.4	7.9	11.9	11.3	4	11.7	0.6	2.4	9.3	2.4	1.5	1.4	2.1	18.3	1.6	1.8	1.4	1	1.8	5.2	3.3	0.8	5.2	5.7	7.2	5.6	10.5	4.9	4.1	5.7	5.9	7.9	6.4	14.9	8.9	9	3.7	0.3	2.5	3.1	5.1	6.7	9.1	8.7	3.9	12.5	5	12.7	991	7.2	4	0	14.2	13.7	3.1	2.7	3.5	9.7	19.2	3.2	0	1.3	10.6	4145.4	23.3	12.7	1.7	7.2	1	1.3	10.6	0.8	17.3	17.4	5.7	12.9	2.1	35.9	21.3	1	27.7	2.5	1.9	5.1	Late spermatids
ASB5		ENSG00000164122	Ankyrin repeat and SOCS box containing 5	Q8WWX0	4	176213673-176277571	Predicted intracellular proteins, Predicted membrane proteins	Ubl conjugation pathway			Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in many	4	skeletal muscle: 133.4	Cell type enriched	Detected in some	5	Late spermatids: 229.8	Cancer enhanced	Detected in some		prostate cancer: 1.6	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	16	LHCN-M2: 165.0	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA028870			Approved	Plasma membrane						Plasma membrane		HPA028870: AB_10611679					unprognostic (1.76e-1)	prognostic unfavorable (5.67e-4)		unprognostic (1.90e-1)			unprognostic (7.38e-2)	unprognostic (1.32e-1)	unprognostic (1.06e-2)	unprognostic (4.28e-2)	unprognostic (1.65e-1)		unprognostic (6.80e-3)	2.3	0	0.3	0.3	0.2	0	0	0.2	0.2	0.3	3.5	0	0	0.1	0.2	6.3	7.9	0	0.4	1.3	0.2	0.2	0.3	0	0.1	0	0.5	0	0	0	0.1	0.2	0	0	9.6	1.3	0	8	0.1	133.4	0	0.5	23.5	1	0	2	2.2	0	0	2.3	31.4	2.2	15	3.3	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	4	0	3.6	7.8	0	0	0	0	0	0.3	0	0	0	8.8	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	165	0	0	0	0	0	0	0	10.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0.2	0.2	0.2	0.2	0.2	0.5	0	0	0	0	0	0	0	0	0	3.9	0	0	0	0	0	0	0	0	46.8	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	229.8	1.1	0	0	0	0	0	0	0	1.1	0	0	0	0	0.9	0.7	0	0	0	0	0	Late spermatids
RAPSN	CMS1D, CMS1E, RNF205	ENSG00000165917	Receptor associated protein of the synapse	Q13702	11	47437757-47449178	Disease related genes, Predicted intracellular proteins			Congenital myasthenic syndrome, Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in some	11	skeletal muscle: 45.3;tongue: 14.8	Cell type enriched	Detected in some	4	Late spermatids: 10.0	Low cancer specificity	Detected in some			Not detected	Not detected			Cell type enhanced	Detected in single		neutrophil: 2.6	Low lineage specificity	Detected in single			Cell line enriched	Detected in some	4	RH-30: 72.9	Low region specificity	Detected in single							HPA039475	Approved		Approved	Plasma membrane,Centrosome,Cytosol						Plasma membrane, Centrosome, Cytosol		HPA039475: AB_10794196	unprognostic (5.37e-2)	unprognostic (1.02e-1)	unprognostic (7.34e-2)	unprognostic (4.58e-2)	unprognostic (2.95e-2)	unprognostic (1.44e-1)	unprognostic (2.62e-2)	unprognostic (1.77e-3)	unprognostic (1.35e-1)	unprognostic (5.38e-2)	unprognostic (4.81e-2)	unprognostic (2.89e-2)	unprognostic (1.08e-2)	unprognostic (1.64e-4)	unprognostic (3.83e-1)	unprognostic (4.73e-3)	unprognostic (4.48e-2)	1.7	0.8	0.2	0.1	0.2	0.2	0.1	0	0.2	0	0.4	0	0	0.1	0	2.7	0.7	0.1	0.1	1.4	0.4	0	0.1	0.2	0.2	0.1	0.7	0	0	0.1	0	0	1.2	0.3	0.4	0	0.3	0.8	0	45.3	0.2	0.2	0.1	0.2	0.3	0.1	0.2	0.1	0.1	0.4	14.8	0.4	0	0	0.2	0.1	2.6	0.5	0	0.7	0	0	0	0	0.1	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0.3	1.5	0.1	0	0	0	0	0	0	0	17.5	0	0	0	0	0	0	0	72.9	0	0	0.1	0	0	0	0	0	0	0	0	0.1	0	0.1	0	0.1	0.1	0	0	0	0	0	0.1	0.5	0.2	0.6	0	0.2	0	0.1	0.1	0	0.2	0.7	0	2.6	0	0.1	0.1	0	0	0.2	0.2	0	0.2	0.4	0	0.7	0	0.3	0.1	0	0	0	0.1	0	0	1.1	0	0	1.2	0	0	0	0	0.4	2.4	0	0	0	0.2	0.1	0.2	0	0	0.9	0.2	0	0	0	0.3	10	0	0	0	1	0	1	0.4	0	0	0	0	0	0	0	0.4	0	0.2	0	0	0.1	Late spermatids
GPX4	MCSP, PHGPx	ENSG00000167468	Glutathione peroxidase 4	P36969	19	1103926-1106791	Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins		Developmental protein, Oxidoreductase, Peroxidase	Dwarfism	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in all	4	Late spermatids: 13901.3	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			CAB008630, HPA047224, HPA058546	Enhanced		Approved	Nucleoplasm,Mitochondria	Intracellular and membrane				220000	Nucleoplasm, Mitochondria		CAB008630: AB_1616685, HPA047224: AB_2679990, HPA058546: AB_2683749	unprognostic (8.42e-3)	prognostic favorable (7.18e-4)	unprognostic (8.14e-3)	prognostic favorable (1.84e-5)	unprognostic (1.00e-1)	unprognostic (8.72e-2)	unprognostic (2.53e-3)	unprognostic (8.49e-2)	unprognostic (2.69e-2)	unprognostic (1.47e-1)	prognostic favorable (7.72e-4)	unprognostic (1.29e-1)	prognostic favorable (8.61e-4)	unprognostic (1.61e-2)	unprognostic (2.20e-1)	unprognostic (6.67e-3)	unprognostic (2.96e-2)	163	76.4	63.3	27.1	73.7	33.3	102.3	33.5	83.7	53.3	49.1	42.4	33.8	56.9	27.2	74.7	35.6	38.4	46.9	64.4	54.2	60.2	75.3	119	44.7	41.7	74.6	47.3	47.1	35.1	33.1	54.7	46.4	49.3	44.7	25.5	82.3	61.6	46.9	98.2	36.3	58.5	43.6	46.5	32.4	27.7	170.4	36.5	29.9	52.8	49.8	39.2	51.2	47	56.7	64	85.2	85.2	28.4	58.5	110.5	28.7	32.7	47.3	100	143.5	85.1	52.7	22.8	82.3	43.5	44.4	66.7	39	10.4	24.9	46	36.8	32.4	27.6	33	21.3	58.3	49.9	19.6	29.4	94.1	83.5	23	31.5	84.4	50.3	22	37.1	78.5	60.8	36.5	27.4	26.3	35.9	73.8	38.9	39.5	44.8	64.1	52.8	53.9	6.4	30.1	47.2	71.5	40.8	25.8	44.7	42.4	46.4	30.3	41.4	56.3	51.4	46.3	30.8	79.3	28.5	92.2	62.5	24.3	43.6	46.2	26.5	75.6	85.2	85.2	37	62	43	56.7	54.3	38.6	64	47.8	58.5	41.7	42.4	28.4	68.3	44.1	46.8	110.5	63.3	73.7	33.5	83.7	54.2	60.2	74.6	47.3	49.3	36.5	166.7	171	287.8	409.7	453	334.7	225.6	313.4	467.1	233.2	448.4	92.3	508.2	1349.6	448.1	3338.1	251.8	690.8	163.5	318.5	1086.5	512.4	561.5	339.3	667.2	1047.6	197	381.4	302	479.7	13901.3	356.4	828.7	642.7	2643.8	270.1	239.3	473.5	361.2	294.2	2040.3	183.4	239.3	381.6	862.4	171.8	408.3	818	223.7	258.1	558.8	Late spermatids
UBXN6	UBXD1, UBXDC2	ENSG00000167671	UBX domain protein 6	Q9BZV1	19	4444999-4457822	Plasma proteins, Predicted intracellular proteins	Ubl conjugation pathway			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in all	4	Late spermatids: 1030.1	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA040906, HPA041313, HPA061872	Approved		Approved	Golgi apparatus,Cytosol						Golgi apparatus, Cytosol		HPA040906: AB_10794997, HPA041313: AB_10795004, HPA061872: AB_2684629	unprognostic (1.53e-1)	unprognostic (3.18e-2)	unprognostic (2.50e-2)	prognostic favorable (5.68e-5)	unprognostic (1.67e-1)	unprognostic (2.65e-3)	unprognostic (1.83e-2)	unprognostic (1.41e-2)	unprognostic (1.09e-1)	unprognostic (3.48e-1)	prognostic favorable (6.95e-4)	unprognostic (3.93e-2)	prognostic favorable (2.78e-5)	unprognostic (4.61e-2)	unprognostic (2.67e-1)	unprognostic (1.43e-1)	unprognostic (1.79e-1)	29.1	47.7	29	20	38	38.4	22.9	30.5	45.9	21	21.8	12.4	42.3	26.2	23.3	45.9	26.3	24.9	35.6	35.1	29.7	21.8	29.2	37.6	23.4	26.6	25.4	30.5	35.1	45.3	18.9	35.6	22.9	23.3	23.7	8.1	20.8	42.1	46.7	72	25.4	28.9	30.3	21.7	22.2	22.8	41.5	18.4	11.9	38.8	42.2	12	26.9	22.5	7.4	13.6	12.9	10.3	3.6	8.7	6.1	21.1	14.9	7.2	15.5	18.2	22.7	10.8	21.7	25.9	15.9	16.9	9.2	17.9	9.5	19.8	21.3	8.1	12.3	5.5	16.6	5.8	16.6	12	7.9	15.8	12.2	30	9.9	15.9	20.6	22	12.4	12.1	19.4	19.3	13.1	16.2	25.8	11.7	13.4	19.6	16.8	11.5	8.2	13.1	9	10.3	22.3	15	13.3	20.9	30.3	12.1	12.6	35.2	3.5	14.9	16.2	23.2	21.1	16.3	44.9	14.2	58.1	22.8	9.4	40.4	18.6	18.7	8.5	9.2	12.9	5.5	10.3	8.7	6.8	6.5	7.3	8.9	7.4	7.7	6.1	9.1	3.6	6	13.6	6.9	6.1	29	38	30.5	45.9	29.7	21.8	25.4	30.5	23.3	18.4	38.7	26.7	33.5	31.1	33.1	37.4	40.3	53.5	13.4	14.8	41.8	25.5	47.8	68	49.1	229.6	25.1	103.4	163.5	56.3	38	42.3	43.5	34.5	55.5	48	12.7	45	38.1	35.1	1030.1	92.6	36.5	50.6	50.5	58.2	45.3	60	59.6	68.6	86.4	28.5	71.1	28.3	142.6	29.6	35.9	66.6	27.7	54.3	44.3	Late spermatids
KLK13	KLK-L4	ENSG00000167759	Kallikrein related peptidase 13	Q9UKR3	19	51056206-51065114	Cancer-related genes, Enzymes, Predicted secreted proteins		Hydrolase, Protease, Serine protease	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	5	esophagus: 100.5	Cell type enriched	Detected in some	7	Late spermatids: 184.3	Cancer enhanced	Detected in many		head and neck cancer: 42.3	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	11	HaCaT: 20.8	Not detected	Not detected							HPA062136	Enhanced				Secreted in other tissues							HPA062136: AB_2684694	unprognostic (1.99e-3)	unprognostic (1.89e-1)	unprognostic (1.25e-1)	unprognostic (3.66e-2)		unprognostic (3.43e-1)		unprognostic (2.99e-2)	unprognostic (1.69e-1)	unprognostic (6.76e-2)	unprognostic (2.18e-2)	unprognostic (8.30e-2)	unprognostic (7.07e-6)	unprognostic (7.33e-2)	unprognostic (2.53e-1)	unprognostic (6.38e-2)	unprognostic (7.06e-2)	0.1	0.1	0.1	0.1	0.1	0	0.3	0.1	0.2	15.7	0.4	0.2	0.1	0.2	0.3	0.1	100.5	0.2	0.9	0.1	0.1	0	0.1	0.1	0.2	0.1	0.1	0.1	0.4	1.7	0	0.5	0.1	0.2	0.1	0	0.3	12.4	0.1	1.2	2.1	0.4	0.1	0.1	0.1	0.2	6.1	0.1	0.1	0.1	17.9	12.8	0.1	19.4	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	1.8	0	0	20.8	0.4	0	0	0	0	0	0	0	0	0	0.5	0.3	0	0	0	0	0	0.2	1.9	0	0	0	0	0	0.3	0	0	0	0.1	0	0	0	0	0	0	0	0.1	0.2	0.4	1.1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0.7	0	0	0	0.2	0.3	0	0	0	0	0	0	0.1	0.1	0.1	0.2	0.1	0	0.1	0.1	0.2	0.1	0	0	0	0.6	1.8	0	0.4	0	0	6.8	0	0	0	0	0	27.9	0.1	0	0	1.2	0	0	0.7	0	0	0	0	1.7	0	0	184.3	0.3	0	1.7	0	0	0	0.3	0	0.4	0	0	0	0	0.7	0.7	1.1	0	0	0	2	Late spermatids
KRT74	K6IRS4, KRT5C, KRT6IRS4	ENSG00000170484	Keratin 74	Q7RTS7	12	52565782-52573825	Disease related genes, Predicted intracellular proteins			Disease mutation, Ectodermal dysplasia, Hypotrichosis	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	8	epididymis: 11.9;skin 1: 17.2	Cell type enriched	Detected in single	4	Late spermatids: 2.0	Not detected	Not detected			Not detected	Not detected			Cell type enriched	Detected in single	4	memory CD8 T-cell: 1.0	Lineage enriched	Detected in single	10	T-cells: 1.0	Cell line enhanced	Detected in single		HaCaT: 2.6					Not detected	Not detected			HPA048596	Enhanced											HPA048596: AB_2680457		unprognostic (6.75e-3)		unprognostic (3.93e-1)		unprognostic (1.60e-1)		unprognostic (2.49e-2)		unprognostic (9.46e-2)		unprognostic (2.29e-1)			unprognostic (8.54e-2)		unprognostic (1.02e-1)	0.4	0	0.1	0.1	0.1	0	1.8	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	11.9	0.2	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	17.2	0.1	0.1	0.4	0.1	0	0.8	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	1	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	2.6	0	0.2	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0.2	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0.1	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0.2	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0.1	0	0	0.3	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	Late spermatids
SPATA3	TSARG1	ENSG00000173699	Spermatogenesis associated 3	Q8NHX4	2	230990324-231025055	Predicted intracellular proteins, Predicted membrane proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	42	testis: 82.0	Cell type enriched	Detected in some	5	Late spermatids: 3891.5	Not detected	Not detected			Not detected	Not detected			Cell type enhanced	Detected in single		neutrophil: 1.5	Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		BEWO: 3.6;U-698: 1.7	Low region specificity	Detected in many			Region enriched	Detected in single	11	cerebellum: 11.0	HPA018254	Enhanced											HPA018254: AB_1857419					unprognostic (6.94e-3)									unprognostic (6.98e-2)	unprognostic (9.62e-2)			0	0	0	0	0	0	0	0	0.1	0	0	0	0.2	0	0	1.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	82	0	0	0	0	0	0	0	0.5	0.4	1.5	0.2	0.2	0.3	0	0.1	0.3	0.2	0.1	0	0.2	3.6	0.1	0	0	0	0.3	0.1	0.1	0.2	0.2	0	0	0.1	0.5	0.1	1.1	0	0.2	0.3	0	0	0	0.1	0.6	0	0	0.2	0.4	0.3	0.1	0	0.1	0	0.9	0	0.2	0.7	0	0.2	0	0.1	0	0	0.3	0.1	0.1	0.2	0.8	0	0.3	0.2	0	1.1	0.3	0.1	0.1	0	0	0	1.7	0.1	0.1	0	0.4	0.2	0.3	0.2	0.2	0.1	0.3	0.3	0	0.2	0.5	0	0	1.5	0.2	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	761.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3891.5	20.8	0	0	0	0	0	0	0	12.4	0	0	6.5	0	21.5	10.9	0	0	0	0	0	Late spermatids
PHOSPHO1		ENSG00000173868	Phosphoethanolamine/phosphocholine phosphatase	Q8TCT1	17	49223362-49230766	Enzymes, Predicted intracellular proteins	Mineral balance	Hydrolase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	4	blood: 80.0;testis: 52.3	Cell type enriched	Detected in some	6	Late spermatids: 1098.7	Low cancer specificity	Detected in some			Group enriched	Detected in many	4	cerebral cortex: 10.2;pons and medulla: 8.2	Group enriched	Detected in some	171	eosinophil: 30.6;neutrophil: 80.0	Lineage enriched	Detected in single	248	granulocytes: 80.0	Cell line enhanced	Detected in some		Daudi: 8.6;EFO-21: 5.8;HDLM-2: 6.1;SuSa: 8.9	Low region specificity	Detected in all							HPA065025			Approved	Plasma membrane,Actin filaments						Actin filaments	Plasma membrane	HPA065025: AB_2732727	unprognostic (1.37e-1)	unprognostic (3.01e-3)	unprognostic (7.53e-2)	unprognostic (4.41e-3)	unprognostic (1.57e-1)	unprognostic (4.70e-2)	unprognostic (1.44e-1)	unprognostic (1.39e-2)	unprognostic (2.04e-1)	unprognostic (6.88e-2)	unprognostic (1.02e-2)	unprognostic (2.88e-1)	unprognostic (2.03e-1)	unprognostic (1.45e-1)	unprognostic (1.62e-1)	unprognostic (1.08e-1)	unprognostic (1.87e-1)	2.5	1.3	1.1	2.9	1.9	15.3	0.7	1	10.2	0.6	0.6	0.2	0.2	2.5	0.9	2.7	0.9	1.3	2.1	1	1.7	1.3	1	0.9	2.5	2	2.1	1.5	1.1	1	0.1	0.8	7.6	8.2	0.9	0	1.6	0.9	0.5	2.2	1.1	2.6	0.3	1.5	12.6	0.7	52.3	0.1	0	0.8	0.1	0.1	1.4	1.3	0	0	80	0.3	0	0	0.1	0	1.1	0	2	0.1	0.2	0	0.3	0.4	0	0.1	2.7	0	8.6	5.8	0	3.3	0	1.6	0.5	0.1	6.1	0.2	1.2	1.1	0.4	0	0	1.1	0.4	0	0.6	0	0.6	0	1.1	0	0	0.6	0.1	0	0.4	0	0.3	1.6	1.7	3.2	0	0.1	0	0	0	0.3	0.1	0	8.9	0.2	0.1	3.5	0.4	2.8	1.9	0	0.2	0.3	0.6	2.5	3.3	0.3	0	0.1	30.6	0	0.3	0	0	0	0	0	0	0	0	80	0	0.3	0	0	0.1	1.1	1.9	1	10.2	1.7	1.3	2.1	1.5	8.2	0.1	0	0	0	0	0.2	0.3	0.4	0	0	0	0	0	7.5	0	0	185.3	0.1	0	0	0	0.9	0.1	0	0	0	2.3	0	0	0.6	0	1098.7	7.2	0	0	0	0	0.2	0	0	5.6	0	0.4	0	0	8.2	3.8	0	198.7	0	0	0	Late spermatids
PCP2	GPSM4, MGC41903	ENSG00000174788	Purkinje cell protein 2	Q8IVA1	19	7631611-7633748	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	5	brain: 45.5;retina: 20.2;testis: 80.7	Cell type enriched	Detected in many	5	Late spermatids: 3770.2	Low cancer specificity	Detected in many			Region enriched	Detected in some	14	cerebellum: 45.5	Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		HMC-1: 9.1;Karpas-707: 4.6;NB-4: 18.4	Region enriched	Detected in some	43	cerebellum: 2422.3	Region enriched	Detected in some	18	cerebellum: 135.0	HPA057428			Approved	Nuclear speckles,Vesicles		Yes				Nuclear speckles	Vesicles	HPA057428: AB_2683436	prognostic favorable (7.93e-4)	unprognostic (6.06e-2)	unprognostic (1.19e-2)	unprognostic (4.43e-2)	unprognostic (1.49e-1)	unprognostic (1.79e-4)	unprognostic (1.19e-1)	unprognostic (4.88e-5)	unprognostic (1.11e-1)	unprognostic (6.23e-2)	unprognostic (9.15e-3)	unprognostic (6.01e-2)	unprognostic (1.36e-2)	unprognostic (8.17e-2)	unprognostic (1.18e-1)	unprognostic (8.70e-2)	prognostic favorable (2.76e-5)	0.5	0.4	0.5	0.5	0.5	1.9	3.3	45.5	0.6	1	0.5	0.5	0.5	0.6	0.5	2	0.5	1.3	1.2	0.5	0.5	0	2.5	1	1.2	1.4	0.5	0.5	0.5	1.6	0.3	0.5	0.5	3.2	2	0	20.2	10.6	1	0.5	4.2	0.5	0.5	1.9	1.1	0.9	80.7	0.5	0.5	1.9	0.5	0.6	0.5	0.5	1	1.7	2.6	0.3	0.7	1.2	5.2	1.8	0.4	0	0.2	0	0	0.8	0	0	0	0	1.7	1.7	0.8	1.2	0	0	1.4	0	0.2	0	0.8	0.6	2.8	2.5	0.1	0	0.3	9.1	0	0.6	0	0	0	0	0.7	0.2	4.6	0	0.3	0.4	18.4	0.4	0.3	0	0.8	0.2	0.7	0.9	0.1	0.1	0	1.5	1.6	0	0.4	4	3.4	0.2	0	0.6	0.4	0.1	1.6	0.6	0.2	0	2.1	0	0	0.3	0	0.9	0.1	1.2	0.4	0.5	0.5	0.5	1	0.8	1	2.6	0.7	0	1.7	0.2	5.2	0.5	0.5	45.5	0.6	0.5	0	0.5	0.5	3.2	0.5	0	2.9	0	0.8	0.7	166.8	0	0	0	2.3	5.2	21.6	0.2	8.3	0.6	765.5	0	0.6	0	0.2	0	0	1.2	1.1	0	0.4	22.3	0	0	1.2	3770.2	9.8	1	1.7	1.8	0.2	24.5	0.5	0	12.4	0.3	79.8	19.4	0	11.1	6.4	1	0	1.5	0.5	0.6	Late spermatids
TP53I11	PIG11	ENSG00000175274	Tumor protein p53 inducible protein 11	O14683	11	44885903-44951306	Predicted intracellular proteins, Predicted membrane proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	4	Late spermatids: 322.1	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in many		neutrophil: 23.7	Low lineage specificity	Detected in all			Cell line enhanced	Detected in many		SCLC-21H: 85.0;T-47d: 47.9	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA059727, HPA061276	Uncertain		Supported	Endoplasmic reticulum,Golgi apparatus						Endoplasmic reticulum, Golgi apparatus		HPA059727: AB_2684113, HPA061276: AB_2684461	prognostic unfavorable (7.33e-5)	unprognostic (1.87e-1)	unprognostic (4.03e-2)	unprognostic (3.44e-1)	unprognostic (1.38e-1)	unprognostic (2.66e-1)	unprognostic (1.26e-1)	unprognostic (1.50e-1)	prognostic unfavorable (6.12e-4)	unprognostic (6.55e-2)	unprognostic (2.55e-1)	unprognostic (1.92e-1)	prognostic unfavorable (4.65e-4)	unprognostic (2.14e-2)	unprognostic (1.64e-1)	unprognostic (2.09e-1)	unprognostic (1.10e-1)	33.3	8	20	13.3	10.7	19	27.6	36	26.2	14.7	21.1	8.6	17.6	13.6	16.8	10.4	15.6	21.5	28.5	33.1	8.4	12.3	12.5	7.8	21.4	12.8	5.8	8.6	18.2	18.5	3	9.5	16.6	14.1	20.6	19.4	17.6	18.9	11.9	12.6	14.5	21.1	23.5	7.4	28.2	18.4	9.9	5.5	6.7	18.9	12.7	14.9	15.1	19.1	5.2	14.1	23.7	11.1	4.6	4.4	2.1	0	17.7	6	8.6	6.5	0.5	0.1	5.7	11.1	2	2.6	1	0.1	3	4.9	1.5	4.8	3.4	3.4	0.1	0.7	6.5	3.5	0.2	0.2	0	12	0.1	23.9	27.7	0.4	2.8	1.2	0.4	6.6	6.9	0.4	0	2.5	15.1	0.3	27.8	11.1	11	5.9	13.5	3.7	1.4	0	1.1	85	3.1	9.9	21.6	0	7.7	47.9	1.7	1.6	13.3	9.4	20.4	0	0.1	0	0	0	1.7	3.7	0	3.1	0	3.1	3.2	4.4	4.9	0.6	3.2	2.6	5.2	0	1.1	23.7	4.6	11.1	14.1	0.5	2.1	20	10.7	36	26.2	8.4	12.3	5.8	8.6	14.1	5.5	20.8	25.7	5.4	31.5	9.6	0.6	6.7	22.9	9.4	14.8	40.1	0	47	1.7	26	74.9	13.5	12.7	0	18.6	15.1	11.8	25.6	0	0.9	32	0	34.5	80.4	10.5	322.1	11.2	9.6	10.1	13.6	24.2	0.5	28.8	7	7.1	0	0.9	12.9	12.6	2.1	6	3.9	57.1	4.4	45.7	36	Late spermatids
CCDC57	FLJ00130, FLJ23754	ENSG00000176155	Coiled-coil domain containing 57	Q2TAC2	17	82101460-82212830	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	5	Late spermatids: 565.2	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Group enriched	Detected in some	4	naive CD4 T-cell: 5.2;naive CD8 T-cell: 10.7	Lineage enriched	Detected in many	6	T-cells: 10.7	Low cell line specificity	Detected in many											HPA023315, HPA023326, HPA023342, HPA023344	Approved		Approved	Microtubules,Centriolar satellite,Cytosol						Microtubules	Centriolar satellite, Cytosol	HPA023315: AB_1846159, HPA023326: AB_1846160, HPA023342: AB_2275460, HPA023344: AB_1846162	unprognostic (2.51e-3)	unprognostic (8.22e-2)	unprognostic (1.41e-1)	unprognostic (9.92e-3)	unprognostic (1.25e-1)	unprognostic (2.11e-3)	unprognostic (1.33e-1)	unprognostic (1.56e-2)	unprognostic (3.19e-2)	unprognostic (2.16e-1)	prognostic favorable (5.55e-5)	unprognostic (2.07e-1)	prognostic unfavorable (2.28e-6)	unprognostic (5.19e-2)	unprognostic (1.53e-1)	unprognostic (2.04e-1)	unprognostic (3.80e-3)	5.5	9	12.9	10.4	14.1	12.1	14.1	20.3	16.6	9.9	8.5	7.6	17.1	11.8	14.2	13.7	4.2	14.9	11.2	4.7	9.3	6.8	13	6.8	8.8	7.9	5.4	13.7	14	13.7	15.9	22.7	5.8	8.9	14.9	5.2	16.7	13.6	13.8	6.2	8.9	8.9	11.3	3.8	7.7	11.4	23.7	8.8	10.6	19.8	5.2	9.6	7.9	7.2	0.6	1.6	1.9	0.6	0.4	10.7	1.5	4.4	9.1	4.8	6.3	2.9	5.3	5.7	3.5	3.5	2.6	2.2	2.7	7.1	2.4	3.3	2.8	2.6	10.6	1.3	6.3	1.4	2.5	9.5	3.9	15.2	5.8	3.8	3.8	5	5.3	5	4.9	6.4	5.9	3.1	3.5	5	1.3	1.7	6.6	7.2	7.3	1.6	2.6	3.7	4.1	2	3.3	4.9	5.6	16.5	10.3	3.1	15	5.9	3.1	8.8	4.4	3.2	10.1	9.2	4.3	6.9	9.7	1	0.8	7.8	4.3	3.9	0.5	0.6	0.7	0.9	0.2	0.4	0.6	0.8	1.2	0.5	0.6	5.2	10.7	1.9	0.4	0.1	1.6	0.3	1.5	12.9	14.1	20.3	16.6	9.3	6.8	5.4	13.7	8.9	8.8	23.8	60.8	37.4	20.2	10.4	19.7	3.1	17.8	48.2	48.9	27.9	39.3	31.4	8.3	13.7	115.3	5.7	26.4	0	15.5	30.4	7.5	25.4	34.6	86.9	26.3	23.8	41	8	35.8	565.2	7.5	30.7	32.1	26.2	34.7	9.8	13.9	23.2	9.6	7.5	66.2	6.5	10.3	10.8	5.3	15.9	10.4	40.5	26.6	15.3	Late spermatids
C12orf54	MGC35033	ENSG00000177627	Chromosome 12 open reading frame 54	Q6X4T0	12	48482503-48496512	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in single	38	testis: 34.8	Cell type enriched	Detected in many	5	Late spermatids: 2100.5	Group enriched	Detected in some	9	cervical cancer: 2.9;head and neck cancer: 2.1;lung cancer: 1.6;urothelial cancer: 0.7	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	4	HaCaT: 2.8;HBEC3-KT: 9.4;hTCEpi: 2.6;hTERT-HME1: 5.6									HPA073090			Approved	Intermediate filaments						Intermediate filaments		HPA073090: 	unprognostic (2.59e-3)	unprognostic (5.49e-2)	unprognostic (7.94e-3)	unprognostic (2.60e-2)	unprognostic (2.48e-2)	unprognostic (8.99e-2)		unprognostic (5.96e-2)	unprognostic (1.62e-1)	unprognostic (8.01e-2)	unprognostic (1.36e-4)	unprognostic (2.37e-1)	unprognostic (5.06e-3)	unprognostic (7.53e-2)	unprognostic (1.34e-1)	unprognostic (1.97e-1)	unprognostic (1.92e-1)	0.1	0.3	0.2	0.1	0.1	0	0.1	0.1	0.3	0.2	0.1	0.1	0.1	0	0.3	0.1	0.6	0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.6	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.2	0.1	0.1	0.1	0.3	0.1	0.1	0	34.8	0.1	0.1	0.1	0.1	0.9	0.1	0.2	0	0	0	0.5	0	0	0	0	0	0	0.2	0.3	0	0	0	0	0	0	0	0	0	0	0	0	2.8	0	9.4	0	0	0	0	0.9	0	0	0	0	0	2.6	0	5.6	0.2	0	0	0	1.1	0	0	0	0	0	0	0	0	0.2	0	0	0.4	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0.2	0.1	0.1	0.3	0.2	0.1	0.3	0.1	0.1	0.1	0	1.6	0	22.3	4.5	0	0.4	0	0	0	0	0	0.1	1.7	0.1	444.4	0.1	0	0	0	0.1	0.4	4.3	0	0	0.1	0	0	0	0	2100.5	10	1.2	0	0	0	0.2	0	0	12.4	0.2	0	6.5	1.4	12.9	6.4	1.9	0	0	0	8.4	Late spermatids
TSSK6	CT72, FLJ24002, SSTK	ENSG00000178093	Testis specific serine kinase 6	Q9BXA6	19	19512418-19515685	Enzymes, Predicted intracellular proteins	Differentiation, Spermatogenesis	Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	13	testis: 50.8	Cell type enriched	Detected in some	5	Late spermatids: 5597.9	Low cancer specificity	Detected in all			Low region specificity	Detected in many			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		BEWO: 8.0	Not detected	Not detected			Not detected	Not detected																unprognostic (2.12e-1)	unprognostic (7.89e-2)	unprognostic (7.26e-2)	unprognostic (6.64e-2)	unprognostic (3.39e-1)	unprognostic (7.20e-5)	unprognostic (3.38e-1)	unprognostic (5.51e-3)	unprognostic (5.17e-2)	unprognostic (1.46e-1)	unprognostic (3.98e-4)	unprognostic (2.28e-2)	unprognostic (5.34e-3)	unprognostic (2.74e-3)	unprognostic (2.78e-2)	unprognostic (1.52e-3)	unprognostic (9.89e-2)	0.9	1.2	1	1.2	1.5	1.3	1	0.9	1.9	0.9	1.1	2.2	1.6	2.1	0.9	3.7	1.1	1.1	1	0.7	1.2	0.8	1.8	2.2	0.7	1.2	2.5	1	0.9	3.3	1.1	1	0.6	1.3	1.4	0.6	0.9	1.3	1	1	2.7	1.9	1.2	1.9	2.1	1.7	50.8	1.7	3.1	2	0.1	1.7	1.1	1	3.1	1	2.2	0.7	0.4	3.8	0.8	1.6	2.7	0.1	1.1	0.4	1	8	1.1	0.5	0.6	0.3	4.2	1.3	1.4	2	0	0.5	1.4	0.5	1.1	0.2	1	1.9	0.7	1.7	0.9	1.2	0.9	3.2	0.6	1	0.6	1.9	0.6	0.3	5.4	1.9	0.8	0	0.5	3.4	2	3.7	0.8	4.4	2.7	0.7	1.2	0.1	0.5	0.6	2.9	1.6	0.4	1.4	0.4	2.6	0.7	0.3	2	0.6	3.9	1.7	3.5	1.4	0.8	2.2	1.2	1.9	0	0.6	2.2	0.8	0.2	1.1	3.1	1.7	2	0.3	1.9	3.8	2.1	1.1	0.4	0.7	1	1	0.8	1	1.5	0.9	1.9	1.2	0.8	2.5	1	1.3	1.7	0	0	0	0.2	0.3	0	1.2	0	0	0	0	0	0.1	0	0.1	1053.4	0	0	0	0.2	0.1	0	0.2	0	0	0.1	0	0	1.3	0.6	5597.9	44.3	0	1.7	0	0	0	0.1	0	53.7	0.1	0	19.4	0.6	51.3	21.7	0.1	0.1	0	0	0	Late spermatids
LSMEM2	C3orf45, FLJ38608	ENSG00000179564	Leucine rich single-pass membrane protein 2	Q8N112	3	50279027-50288114	Predicted membrane proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in some	6	heart muscle: 26.6;skeletal muscle: 16.3;tongue: 7.2	Cell type enriched	Detected in some	5	Late spermatids: 197.4	Not detected	Not detected			Low region specificity	Detected in many			Cell type enhanced	Detected in single		MAIT T-cell: 1.2	Lineage enriched	Detected in single	13	T-cells: 1.2	Cell line enhanced	Detected in some		HeLa: 3.7;WM-115: 3.5					Low region specificity	Detected in many			HPA079523			Approved	Nucleoplasm,Plasma membrane						Plasma membrane	Nucleoplasm	HPA079523: 	unprognostic (2.84e-3)	unprognostic (6.54e-2)	unprognostic (2.36e-2)	unprognostic (1.09e-1)	unprognostic (1.03e-1)	unprognostic (2.30e-1)	unprognostic (8.96e-2)	unprognostic (1.02e-1)	unprognostic (1.55e-2)	unprognostic (2.65e-1)	unprognostic (3.17e-2)	unprognostic (2.82e-1)	unprognostic (1.82e-1)	unprognostic (2.46e-2)	unprognostic (2.48e-1)	unprognostic (6.49e-3)	unprognostic (1.71e-1)	0.6	0.3	1.2	0.2	2.1	0.4	0.2	0.7	1.9	1.1	0.3	2.1	0.1	0.4	1.4	0.4	0.7	0.8	0.4	26.6	1.4	0.7	0.3	0.1	0.3	0.1	1.3	0.6	0.9	0.3	0.1	0.1	0.2	1.3	0.4	0.3	1.6	1.4	0.5	16.3	0.1	0.5	0.5	1.6	0.2	0.2	3	0.9	0.1	0.2	7.2	0.2	0.3	0.7	0	0	0	0	0	1.2	0	0.1	0.3	0.2	0.3	0	0	0.4	0.4	0.4	0.4	0.2	0.3	0.5	0.1	0.1	0	0.5	0.1	0.1	1.1	0.1	0	0.5	0.2	3.7	0.2	0	0.3	0.2	0.2	0	0.1	0.2	0.5	0	1.1	0	1	0	0.2	0.1	0.7	0.5	0.4	0	0	0.3	0	0.3	0.3	0.1	0.5	0	0.8	1	0.4	0	0	0	0.2	1.3	0.4	0.4	0.9	0.6	0.6	0.1	0.9	3.5	0	0	0	0	0	1.2	0	0.1	0.3	0	0	0.8	0.1	0	0	0	0	0	0	1.2	2.1	0.7	1.9	1.4	0.7	1.3	0.6	1.3	0.9	0	1.1	0	0.1	0.9	0.1	3	0	0	1.2	1.8	0	0	0	0.1	41.7	0	0.9	0	0.2	0.1	0.3	0.3	4.7	0	0.1	0	0	0	0	197.4	1.1	0	1.7	0	0.4	0.5	0.1	0	0.7	0	0.2	0	0.7	1.6	1	1.1	0.1	0	0.6	0.1	Late spermatids
TPPP2	C14orf8, CT152, p18, p25beta	ENSG00000179636	Tubulin polymerization promoting protein family member 2	P59282	14	21024109-21036276	Predicted intracellular proteins	Differentiation, Spermatogenesis			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	21	testis: 99.4	Cell type enriched	Detected in some	4	Late spermatids: 7275.7	Cancer enhanced	Detected in single		liver cancer: 0.5	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		CACO-2: 2.6;HAP1: 1.8;Hep G2: 1.3;RT4: 1.7	Not detected	Not detected			Not detected	Not detected			HPA004120	Enhanced											HPA004120: AB_2303582	unprognostic (2.91e-2)	unprognostic (2.49e-3)	unprognostic (2.54e-1)		unprognostic (1.66e-2)	unprognostic (2.14e-2)	unprognostic (2.57e-3)	unprognostic (4.63e-4)		unprognostic (3.83e-1)	unprognostic (3.16e-1)	unprognostic (1.09e-1)	unprognostic (4.64e-4)	unprognostic (2.51e-4)	unprognostic (1.22e-1)	unprognostic (1.06e-1)	unprognostic (3.21e-1)	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0	0.1	1.8	0.1	0	0.1	0.1	0.1	0	0.2	4.8	0.1	0.1	0.1	0.1	0.2	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.5	0.1	0.9	0	0.1	0.1	0.1	0.1	0	99.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0.4	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	2.6	0	0	0	0	0	0	1.8	0	0	0	0	0	0	1.3	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	1.7	0	0.7	0	0	0	0.6	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0.1	0.1	0.1	0.2	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	0	0	1.4	0	0	0	1.8	0	0	0	0.1	1716.6	0	0	0	0	0	0	0	0	4.3	0	0	0	0	0	7275.7	44	0	0	0	0	0.8	0	0	32.9	0	0	0	0	48.1	24.2	0	0.1	0	0	0	Late spermatids
C3orf22	MGC34728	ENSG00000180697	Chromosome 3 open reading frame 22	Q8N5N4	3	126526999-126558965	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in some	25	testis: 28.3	Cell type enriched	Detected in some	5	Late spermatids: 1235.7	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	13	MCF7: 1.5;SCLC-21H: 1.0					Not detected	Not detected			HPA059199	Enhanced											HPA059199: AB_2683946	unprognostic (2.10e-1)			unprognostic (5.14e-5)	unprognostic (2.55e-1)		unprognostic (9.21e-2)			unprognostic (2.01e-1)		unprognostic (2.75e-1)	unprognostic (1.08e-3)		unprognostic (1.34e-1)			0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	28.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.5	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	232.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1235.7	9.5	0	0	0	0	0	0	0	5.3	0	0	0	0	8.6	3.8	0	0	0	0	0	Late spermatids
SPEM1	C17orf83, FLJ40081	ENSG00000181323	Spermatid maturation 1	Q8N4L4	17	7420360-7421632	Predicted membrane proteins	Differentiation, Spermatogenesis	Developmental protein		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	69	testis: 61.9	Cell type enriched	Detected in some	5	Late spermatids: 3850.1	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		CACO-2: 1.0;hTEC/SVTERT24-B: 1.2;U-2 OS: 3.3	Low region specificity	Detected in single																																		unprognostic (1.28e-1)			0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	61.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.4	0	0	0	0	0	0.1	0.1	1	0	0	0.1	0.5	0.2	0	0.3	0	0.2	0.4	0.2	0	0	0	0	0	0.2	0	0	1.2	0	0	0	0	0	0	0	0.9	0	0	0	0	0	0.3	0.2	0	0	0	0	0.6	0	0	0	0.1	0	0	0	0.5	3.3	0.4	0	0.4	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	833.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3850.1	10.9	0	0	0	0	0	0	0	11.7	0	0	6.5	0	11.5	4	0	0	0	0	0	Late spermatids
ODF3L2	C19orf19, FLJ40059	ENSG00000181781	Outer dense fiber of sperm tails 3 like 2	Q3SX64	19	463346-474983	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	26	skeletal muscle: 12.5;testis: 16.7	Cell type enriched	Detected in some	5	Late spermatids: 894.9	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		AN3-CA: 1.5;BEWO: 2.2;EFO-21: 3.1;HMC-1: 2.3	Low region specificity	Detected in many			Not detected	Not detected			HPA067065, HPA067973	Uncertain		Approved	Nucleoplasm,Nucleoli,Golgi apparatus						Nucleoli	Nucleoplasm, Golgi apparatus	HPA067065: , HPA067973: AB_2685937	unprognostic (3.75e-4)	unprognostic (1.79e-2)	unprognostic (1.83e-3)	unprognostic (9.69e-3)	unprognostic (5.88e-2)	unprognostic (5.65e-2)	unprognostic (9.32e-2)	unprognostic (1.35e-1)	unprognostic (2.34e-2)	unprognostic (1.77e-2)	unprognostic (2.13e-2)	unprognostic (4.06e-2)	unprognostic (2.02e-5)	unprognostic (3.13e-3)	unprognostic (8.99e-2)	unprognostic (3.05e-1)	unprognostic (1.99e-1)	0.4	0.1	0.1	0	0.2	0	0	0	0	0	0			0	0	0	0	0.1	0.1	0	0.1	0.1	0	0.2	0	0	0.2		0	0	0	0	0.3		0.1	0		0	0	12.5	0	0	0	0.3	0.5	0	16.7			0.1		0	0	0	0	0	0	0	0	0	0.3	0	0	0	1.5	0	0	2.2	0	0.1	0.1	0.1	0	0	0.1	3.1	0	0.5	0.1	0	0	0.2	0	0.8	0	0	0	0	0.3	2.3	0	0.3	0	0.2	1.1	0	0	0.6	0.1	0.6	1	0.1	0	0.8	0	0.6	0.1	0	0	0	0	0.1	0.2	0	0.1	0.1	0	0	0.9	0	0.5	0.1	0	0	0.6	0	0	0.1	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3											0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	187	0.1	0	0	0	0	0	0	0	0	0	0	0	7.4	0	894.9	7.8	0	0	0	0	0.1	0	0	4.6	0	0.7	0	0.1	6.4	5.2	0	0	0	0	0	Late spermatids
RABIF	mss4, RASGRF3	ENSG00000183155	RAB interacting factor	P47224	1	202878957-202889135	Predicted intracellular proteins	Protein transport, Transport	Guanine-nucleotide releasing factor		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	5	Late spermatids: 2502.1	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA027715, HPA054936	Approved		Approved	Microtubules,Cytokinetic bridge						Microtubules, Cytokinetic bridge		HPA027715: AB_10602151, HPA054936: AB_2732590	unprognostic (4.87e-2)	unprognostic (3.70e-2)	unprognostic (2.09e-1)	unprognostic (1.37e-1)	unprognostic (3.51e-1)	unprognostic (1.36e-2)	prognostic unfavorable (1.55e-4)	unprognostic (1.70e-1)	unprognostic (5.62e-3)	prognostic favorable (5.64e-5)	unprognostic (4.40e-2)	unprognostic (2.94e-1)	prognostic unfavorable (2.61e-5)	unprognostic (1.23e-1)	unprognostic (5.21e-2)	unprognostic (8.54e-2)	unprognostic (2.47e-1)	7.1	7	13.4	10.3	13.8	14	7.9	11.5	17.9	8.9	10.4	10.9	3.1	9.9	6.3	8.2	13.8	6.2	8.4	6.7	12.7	15.4	11.2	10.9	8.9	11.7	13.4	10.4	4	5.7	6	9.2	11.2	14.5	8.6	11.7	6.6	7.9	6.8	7.4	10.6	12	9.3	18.2	10.2	7	30.2	10.6	8.9	6.3	8.8	15.8	9.4	7.5	15.7	17.7	31.1	21	14.9	18.7	15.6	12.4	13.5	9.6	11	15.2	11.7	10.6	13.9	7.7	14.4	13.5	9.3	10.9	10.3	6.9	11	9.9	11.8	7.6	8.8	10.9	12.2	14.1	8.5	11.1	9.7	12.3	11.6	14.8	9.7	12.7	18.1	4.7	7.2	18.9	13.4	13.4	11.4	14	20.8	12.9	12.6	7.8	9.8	16.7	9.3	13	14.1	14.7	13	13.7	12	12	21.2	10.7	12.5	13.7	8.5	14.5	10.1	9.3	4.6	12.2	6	13.2	11	9.9	10.8	9.3	24.1	20	27.6	18.3	21	13.3	15.7	17.4	17.2	17.7	15.5	15.9	16.7	31.1	14.9	18.8	16.9	18.7	15.6	13.4	13.8	11.5	17.9	12.7	15.4	13.4	10.4	14.5	10.6	0	15.7	22.8	29	48.2	4.6	9.3	7.6	9.4	7.9	12.2	2	43.7	13.3	34	555	24.8	30.4	0	46.5	41.5	19.7	25.2	12.7	28.9	36.9	1.6	22.4	16	37.6	2502.1	26.2	34.4	50.6	48.7	12.4	10.8	58.5	31.6	28.3	47.7	5.7	12.9	27.6	68.8	55.8	45.4	66	26.1	13.4	37.3	Late spermatids
UBL4B	FLJ25690	ENSG00000186150	Ubiquitin like 4B	Q8N7F7	1	110112468-110113945	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	79	testis: 65.3	Cell type enriched	Detected in some	4	Late spermatids: 5150.4	Cancer enhanced	Detected in single		glioma: 0.5	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	5	BJ hTERT+: 21.5	Not detected	Not detected			Not detected	Not detected			HPA031364	Enhanced											HPA031364: AB_10604000	unprognostic (2.92e-1)	unprognostic (3.48e-2)		unprognostic (3.53e-1)	unprognostic (9.81e-2)	unprognostic (1.65e-2)		unprognostic (5.24e-2)	unprognostic (1.29e-2)	unprognostic (3.43e-2)	unprognostic (6.87e-3)	unprognostic (4.46e-1)	unprognostic (2.20e-9)	unprognostic (3.29e-2)	unprognostic (7.39e-2)	unprognostic (1.59e-4)	unprognostic (3.90e-2)	0.2	0	0	0	0.1	0	0.2	0	0.2	0	0	0	0.3	0	0.2	0.8	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0.1	0	0	0	0	0.1	0	0	0	65.3	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.9	21.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	2.7	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1273.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5150.4	27	0	0	0	0	0	0.1	0	20.8	0	0	12.9	0	37.9	15.1	0	0	0	0	0	Late spermatids
CLCNKA	hClC-Ka	ENSG00000186510	Chloride voltage-gated channel Ka	P51800	1	16018875-16034050	Disease related genes, Predicted membrane proteins	Ion transport, Transport	Chloride channel, Ion channel, Voltage-gated channel	Bartter syndrome, Deafness, Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	5	kidney: 46.9;parathyroid gland: 15.4	Cell type enriched	Detected in some	4	Late spermatids: 171.7	Group enriched	Detected in some	7	renal cancer: 4.4;thyroid cancer: 1.6	Region enriched	Detected in single	7	cerebellum: 2.1	Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	4	U-266/70: 13.0									HPA057717	Approved											HPA057717: AB_2683509	unprognostic (2.35e-2)	unprognostic (1.24e-1)	unprognostic (1.37e-2)	unprognostic (4.02e-1)	unprognostic (2.76e-3)	unprognostic (8.20e-2)	unprognostic (6.16e-2)	unprognostic (1.18e-2)	unprognostic (6.92e-3)	unprognostic (3.49e-2)	unprognostic (1.76e-2)	unprognostic (1.41e-1)	unprognostic (8.13e-3)	unprognostic (1.36e-1)	unprognostic (9.13e-2)	unprognostic (4.37e-3)	unprognostic (1.28e-1)	0.2	0.7	0.2	0.2	0.2	0	0.2	2.1	0.2	0.2	0.2	0.2	0.2	0	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0	46.9	0.2	0.2	0.2	0.2	0.2	0.2	1.2	15.4	5.8	0.2	0.2	0.2	0	0.2	4.4	0.2	0.2	0	0.2	0.2	0.2	0.2	1.6	1.1	0.2	0.2	6	0.2	0.2	0.2	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0.1	0	0.1	0.1	0	0	0	0	0	0	0.1	0	0.1	0	0	0	0.2	0	0	0	0	0.2	0	0	0.1	0	0	0	0	0.1	0	0.5	0	0.1	0.4	3.1	0	0	0	0	0	3.2	0.1	0.3	0.2	0.5	0	0	0.1	0	0	13	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.2	2.1	0.2	0.2	0	0.2	0.2	0.2	0.2	3	0.3	0	0	0.1	0.6	3.5	0	0	1.2	24.4	0	0.4	21.6	0.1	38.8	0	0	0	0.2	0	0.5	0.2	0	0	0.1	12.7	1.2	0	0	171.7	0.3	0	1.7	0	0	1.7	0	0	0.4	0	0.4	0	0	1.7	0.7	0	0.6	0	0	0.1	Late spermatids
VSTM1	UNQ3033	ENSG00000189068	V-set and transmembrane domain containing 1	Q6UX27	19	54040825-54063953	Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins	Immunity	Cytokine		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	5	blood: 53.5;bone marrow: 39.4	Cell type enriched	Detected in some	5	Late spermatids: 15.9	Low cancer specificity	Detected in some			Not detected	Not detected			Cell type enriched	Detected in many	15	eosinophil: 53.5	Lineage enriched	Detected in many	15	granulocytes: 53.5	Group enriched	Detected in some	7	EFO-21: 1.0;HMC-1: 2.5;hTERT-HME1: 4.0;U-2 OS: 3.6									HPA059365			Approved	Vesicles	Secreted to blood					Vesicles		HPA059365: 	unprognostic (5.13e-2)	unprognostic (5.31e-2)	unprognostic (1.05e-1)	unprognostic (1.42e-1)	unprognostic (1.36e-3)	unprognostic (1.30e-1)		unprognostic (1.09e-1)	unprognostic (3.80e-1)	unprognostic (1.09e-1)	unprognostic (1.59e-1)	unprognostic (9.47e-2)	unprognostic (1.31e-5)	unprognostic (3.73e-1)	unprognostic (1.14e-1)	unprognostic (9.74e-2)	unprognostic (4.67e-2)	0.9	0.2	0.7	0.1	0.2	39.4	0.1	0	0.5	0.2	0.1	1.3	0	0.1	0.3	0.1	0.1	0.6	0.1	4.2	0.7	0.2	0.5	1.2	4	7.2	0.6	0	0.2	1.1	0.1	8.7	2	0.2	0.1	0.1	0.2	0.1	0.1	2.1	0.1	0.8	0.3	0.1	7.9	0.1	0.5	0.3	3	0.4	0	0.1	0.8	0	0	0	53.5	3.6	0	0	2.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	2.5	0	0	0	4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	3.6	0	0	0	0	0	0	0	0	1.5	3	53.5	0	2.8	0	0	0	0	0	0	0	0	1.1	0	3.6	0	0	2.1	0.7	0.2	0	0.5	0.7	0.2	0.6	0	0.2	0.3	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	0	0	0	2.2	0	0	0	2.2	15.9	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0.1	0	0	0	Late spermatids
SPANXN4	CT11.9, SPANX-N4	ENSG00000189326	SPANX family member N4	Q5MJ08	X	143025918-143034702	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	No human protein/transcript evidence	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	15	testis: 23.7	Cell type enriched	Detected in some	4	Late spermatids: 233.5	Not detected	Not detected			Not detected	Not detected			Cell type enriched	Detected in single	16	neutrophil: 1.5	Lineage enriched	Detected in single	16	granulocytes: 1.5	Cell line enhanced	Detected in some		HEL: 2.4;HeLa: 4.2;hTERT-HME1: 1.0									HPA045730, HPA059094	Uncertain		Approved	Nuclear membrane,Vesicles,Plasma membrane						Vesicles, Plasma membrane	Nuclear membrane	HPA045730: AB_10961036, HPA059094: 																		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	23.7	0	0	0	0	0	0	0	0	0	1.5	0	0	0	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.4	4.2	0	0	0	0.4	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0.3	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.5	0	0	0	0	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	58.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	233.5	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0.3	0	0	0	0	0	Late spermatids
FAM163B	C9orf166	ENSG00000196990	Family with sequence similarity 163 member B	P0C2L3	9	133578415-133586197	Predicted membrane proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	5	brain: 41.7	Cell type enriched	Detected in some	4	Late spermatids: 15.1	Cancer enriched	Detected in some	6	glioma: 3.2					Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	21	SH-SY5Y: 40.0	Low region specificity	Detected in many			Low region specificity	Detected in many			HPA067336	Enhanced		Approved	Nuclear bodies,Plasma membrane,Cytosol						Nuclear bodies, Plasma membrane, Cytosol		HPA067336: AB_2685825	unprognostic (2.94e-2)	unprognostic (6.87e-3)	unprognostic (2.65e-2)	unprognostic (2.70e-1)	unprognostic (1.23e-2)	unprognostic (9.05e-2)	unprognostic (1.02e-2)	unprognostic (3.48e-2)	unprognostic (1.43e-1)	unprognostic (1.16e-1)	unprognostic (3.31e-3)	unprognostic (7.61e-2)	unprognostic (5.75e-4)	unprognostic (1.07e-1)	unprognostic (9.54e-2)	unprognostic (1.65e-1)	unprognostic (4.73e-4)	0.1	8.2	10	0	2.7	0	0	3.2	41.7	0	0.4			0	0	0.3	0	0	0.4	1.2	6.1	3.9	0.1	2.7	0	1.3	3.3		0	0.1	0	0	0.6		0	0.4		0.4	0.7	0	0	0	0	0.9	0	0.1	0.8			0		0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	1.3	0	0	0.5	0.1	0	0	0	1.8	40	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	3.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Late spermatids
TMEM239		ENSG00000198326	Transmembrane protein 239	Q8WW34	20	2816302-2820284	Predicted membrane proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	24	testis: 42.1	Cell type enriched	Detected in some	5	Late spermatids: 109.9	Not detected	Not detected			Not detected	Not detected			Cell type enhanced	Detected in single		neutrophil: 1.7	Low lineage specificity	Detected in single			Cell line enriched	Detected in some	7	HDLM-2: 13.6	Not detected	Not detected			Not detected	Not detected																					unprognostic (5.12e-3)								unprognostic (2.95e-1)				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	42.1	0	0	0	0	0	0	0	0.3	0.3	1.7	0.5	0.3	0.3	0	0	0	0	0.1	0	0.1	0.3	0	0.1	0	0	0	0	0	0	0	0.2	0	0	0	0	13.6	0	0	0	0.1	0	0	0	0.4	0	0.3	0	0	0	0	0	0.1	0	0.1	0	0.1	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	1.8	0	0	0	0	0.1	0	0	0.7	0.5	0.2	0.3	0.2	0	0.1	0.2	0.1	0.1	0.3	0.2	0.2	1.7	0.3	0.1	0.3	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	20.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	109.9	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0.1	0	0	0	0	0	Late spermatids
ASB12	FLJ39577	ENSG00000198881	Ankyrin repeat and SOCS box containing 12	Q8WXK4	X	64224196-64230631	Predicted intracellular proteins	Ubl conjugation pathway			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in some	5	skeletal muscle: 43.4;tongue: 11.5	Cell type enriched	Detected in some	4	Late spermatids: 14.2	Low cancer specificity	Detected in single			Not detected	Not detected			Group enriched	Detected in some	5	basophil: 4.0;naive B-cell: 1.1;T-reg: 1.0	Group enriched	Detected in many	6	B-cells: 1.1;granulocytes: 4.0;T-cells: 1.0	Cell line enhanced	Detected in some		AF22: 3.8;HEK 293: 2.1;HL-60: 2.2;HMC-1: 2.7;JURKAT: 2.2;NB-4: 2.2;NTERA-2: 2.3;REH: 2.1;THP-1: 3.5	Not detected	Not detected			Not detected	Not detected			HPA049542	Uncertain											HPA049542: AB_2680810	unprognostic (6.52e-2)	unprognostic (2.31e-1)	unprognostic (1.48e-2)	unprognostic (1.06e-3)	unprognostic (6.76e-2)	unprognostic (4.23e-2)	unprognostic (6.50e-2)	unprognostic (8.25e-2)	unprognostic (6.75e-2)	unprognostic (9.69e-3)	unprognostic (6.75e-3)	unprognostic (5.18e-2)	unprognostic (5.12e-2)	unprognostic (5.15e-2)	unprognostic (1.35e-1)	unprognostic (4.32e-2)	unprognostic (4.63e-2)	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0.1	2	1	0.7	0	5.9	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0.1	0.2	0	0.6	0.2	43.4	0	0	0.1	0	0	0	0.4	0	0	0.6	11.5	0.7	0	0	1.1	0	4	0.3	0.1	1	0.3	0	0.2	3.8	0	0	0	0	0	0	0	0	0.2	0.6	0.5	0.6	0	0	0	0.9	0	0.4	0	2.1	1.8	0	0	0	2.2	2.7	0	0.5	0	0	0	0	2.2	0.3	1.2	0	0.1	0.5	2.2	2.3	0.5	0.4	2.1	0	0	0.1	0	0	0.6	0	0	0	0.8	0	3.5	0	0	0.1	0.6	0	0	0.1	0.6	0	0	0	4	0	0	0.3	0.3	0.4	0	0.4	0.2	0	1.1	0.3	0.2	0	0.1	0	0	1	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.2	0	0	0	0	0	0.1	0	0.2	3.5	0	0	0	0.3	0	0	0	0	0	0.1	0	0	0	0	14.2	0.3	0	0	0	0	0	0.2	0	0.4	0	0	0	0	0.1	0	0	0.1	0	0	0	Late spermatids
LELP1		ENSG00000203784	Late cornified envelope like proline rich 1	Q5T871	1	153203443-153205120	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	No human protein/transcript evidence	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	65	testis: 147.4	Cell type enriched	Detected in some	5	Late spermatids: 16141.9	Cancer enriched	Detected in single	10	testis cancer: 0.9	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in single		BEWO: 1.6									HPA070231	Enhanced											HPA070231: AB_2686237															unprognostic (1.77e-1)			0	0	0	0	0	0	0	0	0.1	0	0	0	0.4	0	0	2.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	147.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3232.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16141.9	82.3	0	0	0	0	0	0	0	83.8	0	0	45.3	0	103.7	46.9	0	0	0	0	0	Late spermatids
C10orf62	bA548K23.1	ENSG00000203942	Chromosome 10 open reading frame 62	Q5T681	10	97589727-97590934	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	60	testis: 81.1	Cell type enriched	Detected in some	5	Late spermatids: 7737.3	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		AN3-CA: 2.3;Hep G2: 2.9;T-47d: 2.1									HPA072947	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol						Cytosol	Nucleoplasm, Vesicles	HPA072947: AB_2686562		unprognostic (3.66e-2)		unprognostic (3.97e-2)	unprognostic (2.81e-1)		unprognostic (5.36e-2)		unprognostic (3.62e-1)	unprognostic (1.20e-1)	unprognostic (3.63e-2)		unprognostic (2.53e-2)	unprognostic (2.04e-2)				0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	1.3	0	0	0	0.1	0	0	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	81.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	2.3	0	0	0.6	0	0.2	0	0	0.4	0.1	0	0.8	0	0.4	0.1	0	0.3	0	0	0.3	0	0.5	2.9	0	0	0	0.4	0	0.2	0	0	0.2	0	0	0	0	0	0	0.5	0	0	0	0	0.2	0	0.2	0.2	0	0.2	0	0	0	0.1	2.1	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	1574.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	7737.3	36.5	0	0	0	0	0	0	0	35	0.3	0	6.5	0	33.1	18.8	0	0	0	0	0	Late spermatids
CERS1	LAG1, LASS1, UOG1	ENSG00000223802	Ceramide synthase 1	P27544	19	18868545-18896727	Disease related genes, Predicted intracellular proteins, Predicted membrane proteins	Lipid biosynthesis, Lipid metabolism	Transferase	Disease mutation, Epilepsy	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	5	brain: 86.3	Cell type enriched	Detected in some	5	Late spermatids: 85.2	Cancer enhanced	Detected in many		glioma: 13.5	Low region specificity	Detected in all			Cell type enriched	Detected in single	9	neutrophil: 1.7	Lineage enriched	Detected in single	9	granulocytes: 1.7	Cell line enhanced	Detected in many		AN3-CA: 17.7;EFO-21: 13.0;HEK 293: 18.1;NB-4: 19.4;NTERA-2: 13.3									HPA045724	Enhanced		Approved	Endoplasmic reticulum	Intracellular and membrane					Endoplasmic reticulum		HPA045724: AB_10969762	unprognostic (8.25e-2)	unprognostic (8.91e-2)	unprognostic (2.12e-2)	unprognostic (2.14e-1)	unprognostic (3.59e-2)	unprognostic (6.47e-2)	unprognostic (1.15e-2)	unprognostic (1.13e-1)	unprognostic (4.02e-1)	unprognostic (7.04e-3)	unprognostic (3.52e-3)	unprognostic (1.92e-1)	unprognostic (4.59e-2)	unprognostic (2.99e-2)	unprognostic (3.15e-2)	unprognostic (9.15e-2)	unprognostic (3.49e-1)	2.4	4.7	28.9	2.3	32.9	1.7	1.7	12.5	86.3	2.2	2.1	40.5	0	1.6	2	2.1	2.5	2.1	3.9	3.4	29.5	23.2	1.6	1.6	1.9	1.6	31.9	20.5	4.3	2.4	1.7	3.2	1.9	33.8	2	1.8	1.8	2.3	2.1	17.8	2	1.9	3	37.8	1.7	1.8	15.7	22.2	0	2.4	0	1.6	2.6	0.4	0	0	1.7	0.1	0	0.1	0	0.1	1.8	10.9	17.7	0.6	0.2	0.3	1.2	0.1	3.1	2.2	8.7	0.6	0	13	0.8	2.5	0.1	8	0.3	1.2	0	18.1	0.1	0.4	6.5	1.4	1.8	0.2	0.6	0.1	1	0.3	3.5	0.7	0.1	1.1	0.1	2.1	4.5	0.1	19.4	13.3	0	0.3	0	0.3	0.3	2.4	0	9.3	9.3	0.4	0	7.9	3.7	3	10.8	0.3	0	2.5	1.7	2.5	0.3	0.2	0	0	0.6	6.6	0	0	0	0	0.1	0	0	0	0.1	0	0	0.1	0	1.7	0	0	0	0	0	28.9	32.9	12.5	35.7	29.5	23.2	31.9	20.5	33.8	22.2	0	0	0	0.1	0.5	2	0.5	0	0	0	0	2	0	0	0	18.9	0.4	0	0	0.2	0	0.6	0.1	0	0	0.5	0	0	0	0	85.2	1.1	0	1.7	0	0	9.2	0	0	1.1	0	1.2	0	0.3	0.9	2.7	0.4	0.2	0	0	0	Late spermatids
ATXN1L	BOAT1	ENSG00000224470	Ataxin 1 like	P0C7T5	16	71845991-71885268	Predicted intracellular proteins	Transcription, Transcription regulation	DNA-binding, Repressor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	5	Late spermatids: 197.6	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA062596, HPA062789			Enhanced	Nucleoplasm						Nucleoplasm		HPA062596: AB_2684802, HPA062789: AB_2684868	unprognostic (1.51e-1)	unprognostic (1.73e-2)	unprognostic (1.39e-1)	unprognostic (1.67e-1)	unprognostic (3.01e-2)	unprognostic (1.01e-1)	unprognostic (1.68e-1)	unprognostic (1.14e-1)	unprognostic (1.00e-1)	unprognostic (1.04e-1)	unprognostic (8.13e-2)	unprognostic (1.99e-1)	prognostic favorable (5.33e-8)	unprognostic (1.61e-1)	unprognostic (1.42e-1)	unprognostic (5.30e-2)	prognostic unfavorable (8.42e-4)	19.2	12	17.1	14.2	15.9	41.3	16.2	11.9	20.9	15	15.4	22.7	9.1	10.2	19.4	9.8	14.7	14.2	14.5	11.9	13.5	10.9	23.4	10	14.9	11.4	14.7	13.1	16.7	16.3	29.3	10.3	14.6	14.7	14.4	11.9	14.2	14.4	14	15.9	18.6	14.9	16.3	14.5	13.8	16	25.3	16.9	10.9	15.1	8.2	12.9	16.2	18.5	1.8	1.3	3.2	2.1	2	3	1.4	8.5	11.6	11.8	8.6	13.9	6.9	13.9	7.2	8.1	13.2	10.1	16.5	9.6	9.6	11.4	11.3	6	15.1	10	11	14.4	2.6	8.8	7	12.1	11.5	10.4	8.5	14.4	9.9	14.1	14.9	10.8	8.7	11.9	12.7	7.9	7.7	7.7	24.3	14.3	8.4	10.8	6.7	5.5	15.4	12	11.4	9.1	12	6.3	10.8	14.4	7.7	8.8	13	11.9	9.1	14.3	14.5	15.3	9.1	9.7	17.4	14.6	22.9	9	5.8	12.2	3.2	1.5	1.7	2.3	2.1	1.6	1.8	1.7	2	1.3	1.5	3	2.7	2.2	2	0.9	0.8	3	1.4	17.1	15.9	11.9	20.9	13.5	10.9	14.7	13.1	14.7	16.9	0	8.8	10.7	13.3	20.3	11.2	11	7.6	5.3	5.7	14	13.7	7.2	14.9	10.6	37.1	15.7	13.6	0	10.3	6.3	10.5	13	12.7	10.6	7.5	14.3	7.5	13.5	8.8	197.6	13.8	11.3	11.8	15.4	7.5	8	12.2	16.4	12	14	15.5	12.9	14.4	20.4	17.9	21.8	9.6	23.5	8.5	23.8	Late spermatids
KRTAP5-9	KRN1, KRTAP5-1, KRTAP5.9	ENSG00000254997	Keratin associated protein 5-9	P26371	11	71548418-71549553	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in some		epididymis: 5.1;testis: 4.6;urinary bladder: 4.6	Cell type enriched	Detected in single	5	Late spermatids: 4.9	Cancer enhanced	Detected in some		urothelial cancer: 2.0					Cell type enriched	Detected in single	11	myeloid DC: 1.0	Lineage enriched	Detected in single	11	dendritic cells: 1.0	Cell line enriched	Detected in single	20	RT4: 14.4																						unprognostic (1.72e-3)	unprognostic (2.20e-1)	unprognostic (2.22e-2)	unprognostic (2.16e-1)	unprognostic (4.13e-1)	unprognostic (6.53e-2)	unprognostic (8.10e-2)	unprognostic (2.09e-1)	unprognostic (1.06e-1)	unprognostic (7.76e-2)	unprognostic (7.23e-2)	unprognostic (2.56e-1)	unprognostic (3.29e-1)	unprognostic (2.05e-2)	unprognostic (2.01e-1)	unprognostic (4.82e-4)	prognostic favorable (9.25e-4)	0.4	0.4	1.1	0.1	2.8	0.5	0.5	1.3	1.3	0.1	0.9			0.3	0.1	5.1	0.5	0.8	0.9	0.1	1	2	0.4	0.8	0.3	0.3	0.8		0.2	0	1.5	1.1	0.2		0.9	0.7		0.8	1.4	0.4	1.4	0.7	0.1	1	0.7	0.4	4.6			0.4		0.4	4.6	0.1	0	1	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.3	0	0.1	0.4	0.1	0.1	0	0	0	0	0.3	0	0	0	0.1	0.1	0.2	0.2	0.7	0	0	0.1	0	0	0.3	0	0.2	0.1	0.6	0	0.4	0.1	0.5	0	0.1	0	0	0	14.4	0	0.1	0.2	0	0	0	0	0.4	0	0.1	0.1	0.1	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4.9	0	0	0	0	0	0.2	0	0	0	0.1	0.3	0	0	0	0	0	0	0	0	0	Late spermatids
SSTR3		ENSG00000278195	Somatostatin receptor 3	P32745	22	37204238-37212322	FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins		G-protein coupled receptor, Receptor, Transducer	FDA approved drug targets	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in some		brain: 11.1;lymphoid tissue: 29.6;testis: 11.3	Cell type enriched	Detected in single	5	Late spermatids: 1.9	Cancer enhanced	Detected in some		pancreatic cancer: 1.9					Cell type enhanced	Detected in some		naive CD4 T-cell: 3.9;naive CD8 T-cell: 3.0	Lineage enriched	Detected in single	10	T-cells: 3.9	Group enriched	Detected in some	11	RPMI-8226: 22.3;SCLC-21H: 8.4	Low region specificity	Detected in all			Low region specificity	Detected in all			CAB022647	Approved											CAB022647: 	unprognostic (1.63e-2)	unprognostic (5.58e-3)	unprognostic (1.32e-2)	unprognostic (3.18e-2)	unprognostic (7.03e-2)	unprognostic (6.26e-5)	unprognostic (1.11e-1)	unprognostic (1.72e-2)	unprognostic (1.90e-2)	unprognostic (8.95e-2)	unprognostic (3.88e-3)	unprognostic (2.93e-1)	unprognostic (1.51e-7)	unprognostic (1.55e-1)	unprognostic (1.24e-2)	unprognostic (5.61e-3)	unprognostic (1.06e-2)	0.1	0.8	2.8	1.9	1.9	0.9	0.1	2.7	11.1	0	0.5	0.2	0	2.6	1.9	0.2	0.1	0.1	0.1	0	5.6		0.1	0	0.1	3.5	0	7.9	5.8	3.9	0	6.4	0	7.9	0.2	0.6	0	0.6	0.1	0	0	1	2.2	4.3	1.2	0.5	11.3	0.1	29.6	0	0	2	0.3	0	0.3	0.1	0.1	0	0	3.9	0.8	0	0	0	0	0	0	0	0	0	0	0	0.2	0	1	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0.2	0	0.3	0	0	0	0	0	0	0	0	0	22.3	0	0	8.4	0.6	0	0	0	0	0	0	0	0	0	0	0	1.4	0.3	0	0	0	0	0	0	0	0	0	0	0.3	0.9	0	0	0.3	3.9	3	0.1	0	0	0.1	0.3	0.8											0	0	0	0	0	0.3	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.1	0	0	0	0	0	Late spermatids
